BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Demetriou AA. Brown RS Jr, Busuttil RW, Fair J, McGuire BM, Rosenthal P, Am Esch JS 2nd, Lerut J, Nyberg SL, Salizzoni M, Fagan EA, de Hemptinne B, Broelsch CE, Muraca M, Salmeron JM, Rabkin JM, Metselaar HJ, Pratt D, De La Mata M, McChesney LP, Everson GT, Lavin PT, Stevens AC, Pitkin Z, Solomon BA. Prospective, randomized, multicenter, controlled trial of a bioartificial liver in treating acute liver failure. Ann Surg. 2004;239:660-7; discussion 667-70. [PMID: 15082970 DOI: 10.1097/01.sla.0000124298.74199.e5] [Cited by in Crossref: 495] [Cited by in F6Publishing: 338] [Article Influence: 29.1] [Reference Citation Analysis]
Number Citing Articles
1 Gugig R, Rosenthal P. Fulminant hepatic failure in children. Therapy 2008;5:451-63. [DOI: 10.2217/14750708.5.4.451] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
2 Catana AM, Medici V. Liver transplantation for Wilson disease. World J Hepatol 2012;4:5-10. [PMID: 22312450 DOI: 10.4254/wjh.v4.i1.5] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 2.8] [Reference Citation Analysis]
3 Deschamps JY, Roux FA, Saï P, Gouin E. History of xenotransplantation. Xenotransplantation 2005;12:91-109. [PMID: 15693840 DOI: 10.1111/j.1399-3089.2004.00199.x] [Cited by in Crossref: 84] [Cited by in F6Publishing: 49] [Article Influence: 5.3] [Reference Citation Analysis]
4 Gerlach JC, Brayfield C, Puhl G, Borneman R, Müller C, Schmelzer E, Zeilinger K. Lidocaine/monoethylglycinexylidide test, galactose elimination test, and sorbitol elimination test for metabolic assessment of liver cell bioreactors. Artif Organs 2010;34:462-72. [PMID: 20456323 DOI: 10.1111/j.1525-1594.2009.00885.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
5 Giordano C, Rivas J, Zervos X. An Update on Treatment of Drug-Induced Liver Injury. J Clin Transl Hepatol 2014;2:74-9. [PMID: 26356645 DOI: 10.14218/JCTH.2014.00005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
6 Brown SA, Axenfeld E, Stonesifer EG, Hutson W, Hanish S, Raufman J, Urrunaga NH. Current and prospective therapies for acute liver failure. Disease-a-Month 2018;64:493-522. [DOI: 10.1016/j.disamonth.2018.04.002] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
7 Alikhanov RB, Efanov MG, Subbotin VV, Novikova EV, Shchadrina KV, Buldakov MY. [Treatment of severe post-resection liver failure. Analysis of the specialized center]. Khirurgiia (Mosk) 2020;:88-92. [PMID: 33301260 DOI: 10.17116/hirurgia202012188] [Reference Citation Analysis]
8 Ma S, Lin Y, Deng B, Zheng Y, Hao C, He R, Ding F. Endothelial bioreactor system ameliorates multiple organ dysfunction in septic rats. Intensive Care Med Exp 2016;4:23. [PMID: 27447715 DOI: 10.1186/s40635-016-0097-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
9 Yuasa T, Yamamoto T, Rivas-Carrillo JD, Chen Y, Navarro-Alvarez N, Soto-Guiterrez A, Noguchi H, Matsumoto S, Tanaka N, Kobayashi N. Laparoscopy-assisted creation of a liver failure model in pigs. Cell Transplant. 2008;17:187-193. [PMID: 18468249 DOI: 10.3727/000000008783906973] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
10 Sakai Y, Huang H, Hanada S, Niino T. Toward engineering of vascularized three-dimensional liver tissue equivalents possessing a clinically significant mass. Biochemical Engineering Journal 2010;48:348-61. [DOI: 10.1016/j.bej.2009.10.010] [Cited by in Crossref: 25] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
11 Xu X, Liu X, Ling Q, Wei Q, Liu Z, Xu X, Zhou L, Zhang M, Wu J, Huang J, Sheng J, Zheng S, Li L. Artificial liver support system combined with liver transplantation in the treatment of patients with acute-on-chronic liver failure. PLoS One. 2013;8:e58738. [PMID: 23516546 DOI: 10.1371/journal.pone.0058738] [Cited by in Crossref: 36] [Cited by in F6Publishing: 37] [Article Influence: 4.5] [Reference Citation Analysis]
12 Fuhrmann V, Horvatits T, Drolz A, Rutter K. Extrakorporale Therapien bei Patienten mit Lebererkrankungen auf der Intensivstation. Med Klin Intensivmed Notfmed 2014;109:246-51. [DOI: 10.1007/s00063-013-0321-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
13 Walkup MH, Gerber DA. Hepatic Stem Cells: In Search of. Stem Cells 2006;24:1833-40. [DOI: 10.1634/stemcells.2006-0063] [Cited by in Crossref: 56] [Cited by in F6Publishing: 49] [Article Influence: 3.7] [Reference Citation Analysis]
14 Sussman NL, McGuire BM, Kelly JH. Hepatic assist devices: will they ever be successful? Curr Gastroenterol Rep 2009;11:64-8. [PMID: 19166661 DOI: 10.1007/s11894-009-0010-x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
15 Krisper P, Stadlbauer V, Stauber RE. Clearing of toxic substances: are there differences between the available liver support devices? Liver Int 2011;31 Suppl 3:5-8. [PMID: 21824275 DOI: 10.1111/j.1478-3231.2011.02588.x] [Cited by in Crossref: 28] [Cited by in F6Publishing: 17] [Article Influence: 2.8] [Reference Citation Analysis]
16 Whitehouse T, Wendon J. Acute liver failure. Best Pract Res Clin Gastroenterol. 2013;27:757-769. [PMID: 24160932 DOI: 10.1016/j.bpg.2013.08.010] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
17 Hammond JS, Beckingham IJ, Shakesheff KM. Scaffolds for liver tissue engineering. Expert Rev Med Devices 2006;3:21-7. [PMID: 16359250 DOI: 10.1586/17434440.3.1.21] [Cited by in Crossref: 38] [Cited by in F6Publishing: 30] [Article Influence: 2.5] [Reference Citation Analysis]
18 Park J, Berthiaume F, Toner M, Yarmush ML, Tilles AW. Microfabricated grooved substrates as platforms for bioartificial liver reactors. Biotechnol Bioeng 2005;90:632-44. [PMID: 15834948 DOI: 10.1002/bit.20463] [Cited by in Crossref: 119] [Cited by in F6Publishing: 87] [Article Influence: 7.4] [Reference Citation Analysis]
19 Fontana RJ. Acute liver failure including acetaminophen overdose. Med Clin North Am. 2008;92:761-794, viii. [PMID: 18570942 DOI: 10.1016/j.mcna.2008.03.005] [Cited by in Crossref: 136] [Cited by in F6Publishing: 104] [Article Influence: 10.5] [Reference Citation Analysis]
20 Park J, Toner M, Yarmush ML, Tilles AW. Microchannel bioreactors for bioartificial liver support. Microfluid Nanofluid 2006;2:525-35. [DOI: 10.1007/s10404-006-0095-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
21 Bañares R, Catalina MV, Vaquero J. Molecular adsorbent recirculating system and bioartificial devices for liver failure. Clin Liver Dis 2014;18:945-56. [PMID: 25438293 DOI: 10.1016/j.cld.2014.07.011] [Cited by in F6Publishing: 13] [Reference Citation Analysis]
22 Anand AC, Nandi B, Acharya SK, Arora A, Babu S, Batra Y, Chawla YK, Chowdhury A, Chaoudhuri A, Eapen EC, Devarbhavi H, Dhiman RK, Datta Gupta S, Duseja A, Jothimani D, Kapoor D, Kar P, Khuroo MS, Kumar A, Madan K, Mallick B, Maiwall R, Mohan N, Nagral A, Nath P, Panigrahi SC, Pawar A, Philips CA, Prahraj D, Puri P, Rastogi A, Saraswat VA, Saigal S, Shalimar, Shukla A, Singh SP, Verghese T, Wadhawan M; INASL Task-Force on Acute Liver Failure. Indian National Association for the Study of Liver Consensus Statement on Acute Liver Failure (Part-2): Management of Acute Liver Failure. J Clin Exp Hepatol 2020;10:477-517. [PMID: 33029057 DOI: 10.1016/j.jceh.2020.04.011] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
23 Organization Committee of 13th Asia-Pacific Congress of Clinical Microbiology and Infection. 13th Asia-Pacific Congress of Clinical Microbiology and Infection Consensus Guidelines for diagnosis and treatment of liver failure. Hepatobiliary Pancreat Dis Int. 2013;12:346-354. [PMID: 23924491 DOI: 10.1016/s1499-3872(13)60055-7] [Cited by in Crossref: 19] [Cited by in F6Publishing: 10] [Article Influence: 2.7] [Reference Citation Analysis]
24 Wertheim JA, Baptista PM, Soto-Gutierrez A. Cellular therapy and bioartificial approaches to liver replacement. Curr Opin Organ Transplant 2012;17:235-40. [PMID: 22476224 DOI: 10.1097/MOT.0b013e3283534ec9] [Cited by in Crossref: 26] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
25 Larsen FS. Artificial liver support in acute and acute-on-chronic liver failure: . Current Opinion in Critical Care 2019;25:187-91. [DOI: 10.1097/mcc.0000000000000584] [Cited by in Crossref: 19] [Cited by in F6Publishing: 4] [Article Influence: 9.5] [Reference Citation Analysis]
26 Cho CH, Parashurama N, Park EY, Suganuma K, Nahmias Y, Park J, Tilles AW, Berthiaume F, Yarmush ML. Homogeneous differentiation of hepatocyte-like cells from embryonic stem cells: applications for the treatment of liver failure. FASEB J. 2008;22:898-909. [PMID: 17942827 DOI: 10.1096/fj.06-7764com] [Cited by in Crossref: 57] [Cited by in F6Publishing: 48] [Article Influence: 4.1] [Reference Citation Analysis]
27 Liu H, Yu Y, Glorioso J, Mao S, Rodysil B, Amiot BP, Rinaldo P, Nyberg SL. Cold Storage of Rat Hepatocyte Spheroids. Cell Transplant 2014;23:819-30. [DOI: 10.3727/096368913x664847] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
28 Ryska O, Pantoflicek T, Laszikova E, Prazak J, Koblihova E, Ryska M. Artificial liver support system reduces intracranial pressure more effectively than bioartificial system: an experimental study. Int J Artif Organs 2012;35:503-10. [PMID: 22476878 DOI: 10.5301/ijao.5000099] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 1.1] [Reference Citation Analysis]
29 Leckie P, Davenport A, Jalan R. Extracorporeal Liver Support. Blood Purif 2012;34:158-63. [DOI: 10.1159/000342065] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
30 Kuge H, Ohashi K, Yokoyama T, Kanehiro H, Hisanaga M, Koyama F, Bumgardner GL, Kosai K, Nakajima Y. Genetic Modification of Hepatocytes towards Hepatocyte Transplantation and Liver Tissue Engineering. Cell Transplant 2006;15:1-12. [DOI: 10.3727/000000006783982214] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
31 Sakiyama R, Blau BJ, Miki T. Clinical translation of bioartificial liver support systems with human pluripotent stem cell-derived hepatic cells. World J Gastroenterol. 2017;23:1974-1979. [PMID: 28373763 DOI: 10.3748/wjg.v23.i11.1974] [Cited by in CrossRef: 29] [Cited by in F6Publishing: 17] [Article Influence: 7.3] [Reference Citation Analysis]
32 Davidson AJ, Ellis MJ, Chaudhuri JB. A theoretical approach to zonation in a bioartificial liver. Biotechnol Bioeng 2012;109:234-43. [PMID: 21809328 DOI: 10.1002/bit.23279] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
33 Nissen NN, Colquhoun SD. Graft Failure: Etiology, Recognition, and Treatment. Transplantation of the Liver. Elsevier; 2005. pp. 915-28. [DOI: 10.1016/b978-0-7216-0118-2.50066-5] [Cited by in Crossref: 7] [Article Influence: 0.4] [Reference Citation Analysis]
34 Poyck PP, Hoekstra R, van Wijk AC, ten Bloemendaal L, Chamuleau RA, van Gulik TM. Mild Hypothermic Preservation for Transport Purposes of the AMC Bioartificial Liver Charged with Porcine Hepatocytes: . Transplantation 2005;80:1153-60. [DOI: 10.1097/01.tp.0000183958.79272.cb] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
35 Aoki T, Jin Z, Nishino N, Kato H, Shimizu Y, Niiya T, Murai N, Enami Y, Mitamura K, Koizumi T. Intrasplenic transplantation of encapsulated hepatocytes decreases mortality and improves liver functions in fulminant hepatic failure from 90% partial hepatectomy in rats. Transplantation. 2005;79:783-790. [PMID: 15818320 DOI: 10.1097/01.tp.0000156319.47645.3b] [Cited by in Crossref: 42] [Cited by in F6Publishing: 7] [Article Influence: 2.6] [Reference Citation Analysis]
36 Seleverstov O, Bader A. Evaluation of Liver Support Systems for Preclinical Testing by Animal Trials. Artificial Organs 2006;30:815-21. [DOI: 10.1111/j.1525-1594.2006.00305.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
37 Asgari S, Pournasr B, Salekdeh GH, Ghodsizadeh A, Ott M, Baharvand H. Induced pluripotent stem cells: A new era for hepatology. Journal of Hepatology 2010;53:738-51. [DOI: 10.1016/j.jhep.2010.05.009] [Cited by in Crossref: 54] [Cited by in F6Publishing: 47] [Article Influence: 4.9] [Reference Citation Analysis]
38 Shinohara H, Shimada M, Ikemoto T, Morine Y, Imura S, Fujii M, Imaizumi T, Murayama M, Aiba Y. New type of artificial liver support system (ALSS) using the photocatalytic effect of titanium oxide. Dig Dis Sci 2007;52:2271-5. [PMID: 17431780 DOI: 10.1007/s10620-006-9701-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
39 Gu J, Shi X, Zhang Y, Chu X, Hang H, Ding Y. Establishment of a three-dimensional co-culture system by porcine hepatocytes and bone marrow mesenchymal stem cells in vitro. Hepatol Res. 2009;39:398-407. [PMID: 19207578 DOI: 10.1111/j.1872-034x.2008.00472.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
40 Blei AT. Albumin dialysis for the treatment of hepatic encephalopathy. J Gastroenterol Hepatol 2004;19:S224-8. [DOI: 10.1111/j.1440-1746.2004.03678.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
41 Tsuruga Y, Kiyono T, Matsushita M, Takahashi T, Kasai H, Todo S. Establishment of Immortalized Human Hepatocytes by Introduction of HPV16 E6/E7 and hTERT as Cell Sources for Liver Cell-Based Therapy. Cell Transplant 2008;17:1083-94. [DOI: 10.3727/096368908786991542] [Cited by in Crossref: 46] [Cited by in F6Publishing: 20] [Article Influence: 3.5] [Reference Citation Analysis]
42 Bolkhir A, Loiselle M, Evon D, Hayashi P. Depression in primary caregivers of patients listed for liver or kidney transplantation. Progress in Transplantation 2007;17:193-8. [DOI: 10.7182/prtr.17.3.bx6153k7040l7031] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
43 Esrefoglu M. Role of stem cells in repair of liver injury: experimental and clinical benefit of transferred stem cells on liver failure. World J Gastroenterol. 2013;19:6757-6773. [PMID: 24187451 DOI: 10.3748/wjg.v19.i40.6757] [Cited by in CrossRef: 34] [Cited by in F6Publishing: 28] [Article Influence: 4.9] [Reference Citation Analysis]
44 Krisper P, Stauber RE. Technology Insight: artificial extracorporeal liver support—how does Prometheus® compare with MARS®? Nat Rev Nephrol 2007;3:267-76. [DOI: 10.1038/ncpneph0466] [Cited by in Crossref: 59] [Cited by in F6Publishing: 34] [Article Influence: 4.2] [Reference Citation Analysis]
45 Ichai P, Samuel D. Treatment of patients with hepatic failure: the difficult place of liver support systems. J Hepatol. 2004;41:694-695. [PMID: 15464258 DOI: 10.1016/j.jhep.2004.08.004] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
46 Nagaki M, Naito T, Ohnishi H, Akaike T, Muto Y, Moriwaki H. Effects of plasma from patients with fulminant hepatic failure on function of primary rat hepatocytes in three-dimensional culture. Liver Int. 2005;25:1010-1017. [PMID: 16162161 DOI: 10.1111/j.1478-3231.2005.01127.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.1] [Reference Citation Analysis]
47 Zhou P, Huang Y, Guo Y, Wang L, Ling C, Guo Q, Wang Y, Zhu S, Fan X, Zhu M, Huang H, Lu Y, Wang Z. Decellularization and Recellularization of Rat Livers With Hepatocytes and Endothelial Progenitor Cells: Recellularization of Hepatocytes and EPCs. Artificial Organs 2016;40:E25-38. [DOI: 10.1111/aor.12645] [Cited by in Crossref: 42] [Cited by in F6Publishing: 37] [Article Influence: 7.0] [Reference Citation Analysis]
48 Kanjo A, Ocskay K, Gede N, Kiss S, Szakács Z, Párniczky A, Mitzner S, Stange J, Hegyi P, Molnár Z. Efficacy and safety of liver support devices in acute and hyperacute liver failure: a systematic review and network meta-analysis. Sci Rep 2021;11:4189. [PMID: 33602961 DOI: 10.1038/s41598-021-83292-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
49 Sgroi A, Serre-Beinier V, Morel P, Bühler L. What clinical alternatives to whole liver transplantation? Current status of artificial devices and hepatocyte transplantation. Transplantation. 2009;87:457-466. [PMID: 19307780 DOI: 10.1097/tp.0b013e3181963ad3] [Cited by in Crossref: 47] [Cited by in F6Publishing: 14] [Article Influence: 3.9] [Reference Citation Analysis]
50 Damania A, Hassan M, Shirakigawa N, Mizumoto H, Kumar A, Sarin SK, Ijima H, Kamihira M, Kumar A. Alleviating liver failure conditions using an integrated hybrid cryogel based cellular bioreactor as a bioartificial liver support. Sci Rep 2017;7:40323. [PMID: 28079174 DOI: 10.1038/srep40323] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
51 Punzalan CS, Barry CT. Acute Liver Failure: Diagnosis and Management. J Intensive Care Med 2016;31:642-53. [PMID: 26446105 DOI: 10.1177/0885066615609271] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 2.6] [Reference Citation Analysis]
52 Akamatsu N, Sugawara Y. Acute liver failure and living donor liver transplantation. Hepatology Research 2008;38:S60-71. [DOI: 10.1111/j.1872-034x.2008.00429.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
53 Sanchez AP, Balogun RA. Therapeutic Plasma Exchange in the Critically Ill Patient: Technology and Indications. Adv Chronic Kidney Dis 2021;28:59-73. [PMID: 34389138 DOI: 10.1053/j.ackd.2021.03.005] [Reference Citation Analysis]
54 Tissières P, Sasbón JS, Devictor D. Liver support for fulminant hepatic failure: is it time to use the molecular adsorbents recycling system in children? Pediatr Crit Care Med 2005;6:585-91. [PMID: 16148822 DOI: 10.1097/01.pcc.0000170624.29667.7b] [Cited by in Crossref: 37] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
55 Yagi H, Parekkadan B, Suganuma K, Soto-Gutierrez A, Tompkins RG, Tilles AW, Yarmush ML. Long-term superior performance of a stem cell/hepatocyte device for the treatment of acute liver failure. Tissue Eng Part A 2009;15:3377-88. [PMID: 19397469 DOI: 10.1089/ten.TEA.2008.0681] [Cited by in Crossref: 49] [Cited by in F6Publishing: 45] [Article Influence: 4.5] [Reference Citation Analysis]
56 Naiki T, Nagaki M, Asano T, Kimata T, Moriwaki H. Adenovirus-mediated hepatocyte nuclear factor-4α overexpression maintains liver phenotype in cultured rat hepatocytes. Biochemical and Biophysical Research Communications 2005;335:496-500. [DOI: 10.1016/j.bbrc.2005.07.102] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 0.9] [Reference Citation Analysis]
57 Bunchorntavakul C, Reddy KR. Acute Liver Failure. Clinics in Liver Disease 2017;21:769-92. [DOI: 10.1016/j.cld.2017.06.002] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 4.3] [Reference Citation Analysis]
58 Baccarani U, Sanna A, Cariani A, Sainz M, Adani GL, Lorenzin D, Montanaro D, Scalamogna M, Piccolo G, Risaliti A, Bresadola F, Donini A. Cryopreserved human hepatocytes from cell bank: in vitro function and clinical application. Transplant Proc 2005;37:256-9. [PMID: 15808612 DOI: 10.1016/j.transproceed.2004.12.230] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
59 Sakai Y, Nishikawa M, Evenou F, Hamon M, Huang H, Montagne KP, Kojima N, Fujii T, Niino T. Engineering of Implantable Liver Tissues. In: Ochiya T, editor. Liver Stem Cells. New York: Springer; 2012. pp. 189-216. [DOI: 10.1007/978-1-61779-468-1_16] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
60 Ebrahimkhani MR, Neiman JA, Raredon MS, Hughes DJ, Griffith LG. Bioreactor technologies to support liver function in vitro. Adv Drug Deliv Rev. 2014;69-70:132-157. [PMID: 24607703 DOI: 10.1016/j.addr.2014.02.011] [Cited by in Crossref: 94] [Cited by in F6Publishing: 75] [Article Influence: 13.4] [Reference Citation Analysis]
61 Polson J, Lee WM; American Association for the Study of Liver Disease. AASLD position paper: the management of acute liver failure. Hepatology. 2005;41:1179-1197. [PMID: 15841455 DOI: 10.1002/hep.20703] [Cited by in Crossref: 603] [Cited by in F6Publishing: 481] [Article Influence: 37.7] [Reference Citation Analysis]
62 Sauer IM, Baurmeister U. Cell-Free Artificial Liver Support. Therapher Dial 2006;10:105-7. [DOI: 10.1111/j.1744-9987.2006.00350.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
63 Nyberg SL, Amiot B, Hardin J, Baskin-Bey E, Platt JL. Cytotoxic immune response to a xenogeneic bioartificial liver. Cell Transplant 2004;13:783-91. [PMID: 15690980 DOI: 10.3727/000000004783983378] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
64 Wigg AJ, Padbury RT. Liver support systems: Promise and reality. J Gastroenterol Hepatol 2005;20:1807-16. [DOI: 10.1111/j.1440-1746.2005.03965.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
65 Tanaka K, Soto-gutierrez A, Navarro-alvarez N, Rivas-carrillo JD, Jun H, Kobayashi N. Functional Hepatocyte Culture and its Application to Cell Therapies. Cell Transplant 2006;15:855-64. [DOI: 10.3727/000000006783981332] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 6.0] [Reference Citation Analysis]
66 Hoganson DM, Pryor HI 2nd, Vacanti JP. Tissue engineering and organ structure: a vascularized approach to liver and lung. Pediatr Res 2008;63:520-6. [PMID: 18427297 DOI: 10.1203/01.pdr.0000305879.38476.0c] [Cited by in Crossref: 52] [Cited by in F6Publishing: 43] [Article Influence: 4.0] [Reference Citation Analysis]
67 Rebellato LM, Verbanac KM, Haisch CE. The Current Status of Xenotransplantation. Current Surgery 2005;62:481-8. [DOI: 10.1016/j.cursur.2005.01.002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
68 Stravitz RT, Kramer DJ. Management of acute liver failure. Nat Rev Gastroenterol Hepatol. 2009;6:542-553. [PMID: 19652652 DOI: 10.1038/nrgastro.2009.127] [Cited by in Crossref: 127] [Cited by in F6Publishing: 93] [Article Influence: 10.6] [Reference Citation Analysis]
69 Vanholder R, del Canizo JF, Sauer IM, Stegmayr B. The European Artificial Organ Scene: Present Status. Artificial Organs 2005;29:498-506. [DOI: 10.1111/j.1525-1594.2005.29079.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
70 Camus C, Lavoué S, Gacouin A, Compagnon P, Boudjéma K, Jacquelinet C, Thomas R, Le Tulzo Y. Liver transplantation avoided in patients with fulminant hepatic failure who received albumin dialysis with the molecular adsorbent recirculating system while on the waiting list: impact of the duration of therapy. Ther Apher Dial 2009;13:549-55. [PMID: 19954480 DOI: 10.1111/j.1744-9987.2009.00708.x] [Cited by in Crossref: 28] [Cited by in F6Publishing: 18] [Article Influence: 2.5] [Reference Citation Analysis]
71 Ananthanarayanan A, Narmada BC, Mo X, Mcmillian M, Yu H. Purpose-driven biomaterials research in liver-tissue engineering. Trends in Biotechnology 2011;29:110-8. [DOI: 10.1016/j.tibtech.2010.10.006] [Cited by in Crossref: 43] [Cited by in F6Publishing: 30] [Article Influence: 4.3] [Reference Citation Analysis]
72 Ichaï P, Saliba F. [Fulminant and subfulminant hepatitis: causes and treatment]. Presse Med 2009;38:1290-8. [PMID: 19574022 DOI: 10.1016/j.lpm.2009.05.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
73 Chamuleau RA, Deurholt T, Hoekstra R. Which are the right cells to be used in a bioartificial liver? Metab Brain Dis. 2005;20:327-335. [PMID: 16382343 DOI: 10.1007/s11011-005-7914-4] [Cited by in Crossref: 56] [Cited by in F6Publishing: 49] [Article Influence: 3.7] [Reference Citation Analysis]
74 Pless G, Sauer IM. Bioartificial liver: current status. Transplant Proc 2005;37:3893-5. [PMID: 16386576 DOI: 10.1016/j.transproceed.2005.09.113] [Cited by in Crossref: 29] [Cited by in F6Publishing: 21] [Article Influence: 1.9] [Reference Citation Analysis]
75 Takahashi K, Umehara Y, Umehara M, Nishimura A, Narumi S, Toyoki Y, Hakamada K, Yoshihara S, Sasaki M. Plasma Exchange-based Plasma Recycling Dialysis System as an Artificial Liver Support. Therapeutic Apheresis and Dialysis 2008;12:264-70. [DOI: 10.1111/j.1744-9987.2008.00586.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
76 Figaro S, Pereira U, Rada H, Semenzato N, Pouchoulin D, Paullier P, Dufresne M, Legallais C. Optimizing the fluidized bed bioreactor as an external bioartificial liver. Int J Artif Organs 2017;40:196-203. [PMID: 28362045 DOI: 10.5301/ijao.5000567] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
77 Stutchfield BM, Simpson K, Wigmore SJ. Systematic review and meta-analysis of survival following extracorporeal liver support. British Journal of Surgery 2011;98:623-31. [DOI: 10.1002/bjs.7418] [Cited by in Crossref: 80] [Cited by in F6Publishing: 51] [Article Influence: 8.0] [Reference Citation Analysis]
78 Marciniak S, Wnorowski A, Smolińska K, Walczyna B, Turski W, Kocki T, Paluszkiewicz P, Parada-Turska J. Kynurenic Acid Protects against Thioacetamide-Induced Liver Injury in Rats. Anal Cell Pathol (Amst) 2018;2018:1270483. [PMID: 30327755 DOI: 10.1155/2018/1270483] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
79 van de Kerkhove MP, Poyck PP, Deurholt T, Hoekstra R, Chamuleau RA, van Gulik TM. Liver support therapy: an overview of the AMC-bioartificial liver research. Dig Surg. 2005;22:254-264. [PMID: 16174982 DOI: 10.1159/000088055] [Cited by in Crossref: 39] [Cited by in F6Publishing: 26] [Article Influence: 2.4] [Reference Citation Analysis]
80 van Wenum M, Treskes P, Tang CY, Coppens EJ, Jansen K, Hendriks EJ, Camus S, van Gulik TM, Chamuleau RAFM, Hoekstra R. Scaling-up of a HepaRG progenitor cell based bioartificial liver: optimization for clinical application and transport. Biofabrication 2017;9:035001. [PMID: 28664876 DOI: 10.1088/1758-5090/aa7657] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
81 Dutkowski P, De Rougemont O, Müllhaupt B, Clavien PA. Current and future trends in liver transplantation in Europe. Gastroenterology. 2010;138:802-9.e1-802-9.e4. [PMID: 20096694 DOI: 10.1053/j.gastro.2010.01.030] [Cited by in Crossref: 67] [Cited by in F6Publishing: 43] [Article Influence: 6.1] [Reference Citation Analysis]
82 Rikker C. Liver support systems today. Orvosi Hetilap 2009;150:2299-307. [DOI: 10.1556/oh.2009.28769] [Cited by in Crossref: 5] [Article Influence: 0.4] [Reference Citation Analysis]
83 Hata T, Uemoto S, Fujimoto Y, Murakami T, Tateno C, Yoshizato K, Kobayashi E. Transplantation of Engineered Chimeric Liver With Autologous Hepatocytes and Xenobiotic Scaffold. Annals of Surgery 2013;257:542-7. [DOI: 10.1097/sla.0b013e31825c5349] [Cited by in Crossref: 21] [Cited by in F6Publishing: 7] [Article Influence: 2.6] [Reference Citation Analysis]
84 Soto-Gutierrez A, Navarro-Alvarez N, Rivas-Carrillo JD, Chen Y, Yamatsuji T, Tanaka N, Kobayashi N. Differentiation of human embryonic stem cells to hepatocytes using deleted variant of HGF and poly-amino-urethane-coated nonwoven polytetrafluoroethylene fabric. Cell Transplant. 2006;15:335-341. [PMID: 16898227 DOI: 10.3727/000000006783981945] [Cited by in Crossref: 41] [Cited by in F6Publishing: 30] [Article Influence: 2.7] [Reference Citation Analysis]
85 Bachli EB, Schuepbach RA, Maggiorini M, Stocker R, Müllhaupt B, Renner EL. Artificial liver support with the molecular adsorbent recirculating system: activation of coagulation and bleeding complications. Liver Int 2007;27:475-84. [DOI: 10.1111/j.1478-3231.2006.01398.x] [Cited by in Crossref: 44] [Cited by in F6Publishing: 26] [Article Influence: 3.1] [Reference Citation Analysis]
86 Kojima H, Nakamura K, Kupiec-Weglinski JW. Therapeutic targets for liver regeneration after acute severe injury: a preclinical overview. Expert Opin Ther Targets 2020;24:13-24. [PMID: 31906729 DOI: 10.1080/14728222.2020.1712361] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
87 Yokoi T, Oda S, Shiga H, Matsuda K, Sadahiro T, Nakamura M, Hirasawa H. Efficacy of high-flow dialysate continuous hemodiafiltration in the treatment of fulminant hepatic failure. Transfusion and Apheresis Science 2009;40:61-70. [DOI: 10.1016/j.transci.2008.11.006] [Cited by in Crossref: 24] [Cited by in F6Publishing: 18] [Article Influence: 2.0] [Reference Citation Analysis]
88 Yan Q, Zhao XM, Deng LJ, Fang YX, Lin JJ, Li AM. Human hepatocellular adenoma as a promising cell source for bioartificial liver systems. Exp Ther Med 2019;18:1357-65. [PMID: 31316625 DOI: 10.3892/etm.2019.7673] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
89 Tanaka K, Kobayashi N, Gutierrez AS, Rivas-Carrillo JD, Navarro-Alvarez N, Chen Y, Narushima M, Miki A, Okitsu T, Noguchi H. Prolonged survival of mice with acute liver failure with transplantation of monkey hepatocytes cultured with an antiapoptotic pentapeptide V5. Transplantation. 2006;81:427-437. [PMID: 16477231 DOI: 10.1097/01.tp.0000188693.48882.18] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 1.2] [Reference Citation Analysis]
90 Piechota M, Piechota A, Misztal M, Bernas S, Pietraszek-Grzywaczewska I. An evaluation of the usefulness of extracorporeal liver support techniques in patients with severe liver dysfunction. Arch Med Sci. 2019;15:99-112. [PMID: 30697259 DOI: 10.5114/aoms.2017.67998] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
91 Wang N, Tsuruoka S, Yamamoto H, Enosawa S, Omasa T, Sata N, Matsumura T, Nagai H, Fujimura A. The Bioreactor With CYP3A4- and Glutamine Synthetase-Introduced HepG2 Cells: Treatment of Hepatic Failure Dog With Diazepam Overdosage. Artificial Organs 2005;29:681-4. [DOI: 10.1111/j.1525-1594.2005.29107.x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
92 Detry O, De Roover A, Honore P, Meurisse M. Brain edema and intracranial hypertension in fulminant hepatic failure: pathophysiology and management. World J Gastroenterol 2006;12:7405-12. [PMID: 17167826 DOI: 10.3748/wjg.v12.i46.7405] [Cited by in CrossRef: 63] [Cited by in F6Publishing: 50] [Article Influence: 4.5] [Reference Citation Analysis]
93 Blei AT. Monitoring cerebral blood flow: A useful clinical tool in acute liver failure?: Editorial. Liver Transpl 2005;11:1320-2. [DOI: 10.1002/lt.20546] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
94 Shinoda M, Tilles AW, Kobayashi N, Wakabayashi G, Takayanagi A, Totsugawa T, Harada H, Obara H, Suganuma K, Berthiaume F. A bioartificial liver device secreting interleukin-1 receptor antagonist for the treatment of hepatic failure in rats. J Surg Res. 2007;137:130-140. [PMID: 17081566 DOI: 10.1016/j.jss.2006.08.009] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 1.3] [Reference Citation Analysis]
95 Legallais C, Kim D, Mihaila SM, Mihajlovic M, Figliuzzi M, Bonandrini B, Salerno S, Yousef Yengej FA, Rookmaaker MB, Sanchez Romero N, Sainz-Arnal P, Pereira U, Pasqua M, Gerritsen KGF, Verhaar MC, Remuzzi A, Baptista PM, De Bartolo L, Masereeuw R, Stamatialis D. Bioengineering Organs for Blood Detoxification. Adv Healthc Mater 2018;7:e1800430. [PMID: 30230709 DOI: 10.1002/adhm.201800430] [Cited by in Crossref: 20] [Cited by in F6Publishing: 12] [Article Influence: 6.7] [Reference Citation Analysis]
96 Fujii Y, Higashi K, Mizumoto H, Kamihira M, Kajiwara T. A bioartificial liver device based on three-dimensional culture of genetically engineered hepatoma cells using hollow fibers. Cytotechnology 2020;72:227-37. [PMID: 32016712 DOI: 10.1007/s10616-020-00372-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
97 Lee WM, Squires RH Jr, Nyberg SL, Doo E, Hoofnagle JH. Acute liver failure: Summary of a workshop. Hepatology. 2008;47:1401-1415. [PMID: 18318440 DOI: 10.1002/hep.22177] [Cited by in Crossref: 442] [Cited by in F6Publishing: 373] [Article Influence: 34.0] [Reference Citation Analysis]
98 Nicolas CT, Hickey RD, Chen HS, Mao SA, Lopera Higuita M, Wang Y, Nyberg SL. Concise Review: Liver Regenerative Medicine: From Hepatocyte Transplantation to Bioartificial Livers and Bioengineered Grafts. Stem Cells. 2017;35:42-50. [PMID: 27641427 DOI: 10.1002/stem.2500] [Cited by in Crossref: 66] [Cited by in F6Publishing: 48] [Article Influence: 13.2] [Reference Citation Analysis]
99 Minagawa K, Koyama T, Miyoshi H. Stimulating effects of fibroblast growth factors on hepatic function of fetal liver cells synergistically with oncostatin M in three-dimensional culture. J Biosci Bioeng 2009;107:307-11. [PMID: 19269598 DOI: 10.1016/j.jbiosc.2008.10.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
100 Nyberg SL. Bridging the gap: advances in artificial liver support. Liver Transpl. 2012;18 Suppl 2:S10-S14. [PMID: 22767444 DOI: 10.1002/lt.23506] [Cited by in Crossref: 36] [Cited by in F6Publishing: 29] [Article Influence: 4.5] [Reference Citation Analysis]
101 Chan C, Berthiaume F, Nath BD, Tilles AW, Toner M, Yarmush ML. Hepatic tissue engineering for adjunct and temporary liver support: Critical technologies. Liver Transpl 2004;10:1331-42. [DOI: 10.1002/lt.20229] [Cited by in Crossref: 97] [Cited by in F6Publishing: 75] [Article Influence: 5.7] [Reference Citation Analysis]
102 Byrne GW, McGregor CGA, Breimer ME. Recent investigations into pig antigen and anti-pig antibody expression. Int J Surg 2015;23:223-8. [PMID: 26306769 DOI: 10.1016/j.ijsu.2015.07.724] [Cited by in Crossref: 49] [Cited by in F6Publishing: 36] [Article Influence: 8.2] [Reference Citation Analysis]
103 Yura H, Ishihara M, Nakamura S, Kishimoto S, Kanatani Y, Horio T, Ishizuka T, Kawakami M, Matsui T. Coatings of Low-Density Lipoprotein and Synthetic Glycoconjugates as Substrata for Hepatocytes. Artificial Organs 2009;33:419-24. [DOI: 10.1111/j.1525-1594.2009.00746.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
104 Nahmias Y, Yarmush ML. Tissue Engineering Application in General Surgery. In: Meyer U, Handschel J, Wiesmann HP, Meyer T, editors. Fundamentals of Tissue Engineering and Regenerative Medicine. Berlin: Springer Berlin Heidelberg; 2009. pp. 855-67. [DOI: 10.1007/978-3-540-77755-7_59] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
105 Fiegel HC, Kaufmann PM, Bruns H, Kluth D, Horch RE, Vacanti JP, Kneser U. Hepatic tissue engineering: from transplantation to customized cell-based liver directed therapies from the laboratory. J Cell Mol Med. 2008;12:56-66. [PMID: 18021311 DOI: 10.1111/j/1582-4934.207.00162.x] [Reference Citation Analysis]
106 Burra P, Samuel D, Wendon J, Pietrangelo A, Gupta S. Strategies for liver support: from stem cells to xenotransplantation. Journal of Hepatology 2004;41:1050-9. [DOI: 10.1016/j.jhep.2004.10.003] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
107 Huang D, Gibeley SB, Xu C, Xiao Y, Celik O, Ginsberg HN, Leong KW. Engineering liver microtissues for disease modeling and regenerative medicine. Adv Funct Mater 2020;30:1909553. [PMID: 33390875 DOI: 10.1002/adfm.201909553] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 7.0] [Reference Citation Analysis]
108 Stutchfield BM, Forbes SJ, Wigmore SJ. Prospects for stem cell transplantation in the treatment of hepatic disease. Liver Transpl. 2010;16:827-836. [PMID: 20583084 DOI: 10.1002/lt.22083] [Cited by in Crossref: 51] [Cited by in F6Publishing: 42] [Article Influence: 4.6] [Reference Citation Analysis]
109 Fontana RJ, Bari K. Acute Liver Failure. In: Schiff ER, Maddrey WC, Reddy KR, editors. Schiff's Diseases of the Liver. Oxford: John Wiley & Sons, Ltd; 2017. pp. 411-31. [DOI: 10.1002/9781119251316.ch17] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
110 Moniaux N, Faivre J. Will nano-fibers permit to turn liver cell transplantation into a curative tool against liver failure? Journal of Hepatology 2010;52:150-2. [DOI: 10.1016/j.jhep.2009.10.027] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
111 Catapano G, Patzer JF 2nd, Gerlach JC. Transport advances in disposable bioreactors for liver tissue engineering. Adv Biochem Eng Biotechnol 2009;115:117-43. [PMID: 19499208 DOI: 10.1007/10_2008_34] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 0.1] [Reference Citation Analysis]
112 Krisper P, Tiran B, Fliser D, Haditsch B, Stadlbauer V, Otto R, Ernst T, Kretschmer U, Stauber RE, Haller H, Holzer H, Manns MP, Rifai K. Efficacy and Safety of Anticoagulation With Heparin Versus Heparin Plus Epoprostenol in Patients Undergoing Extracorporeal Liver Support With Prometheus. Artificial Organs 2010;34:84-8. [DOI: 10.1111/j.1525-1594.2009.00793.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
113 Nedredal GI, Elvevold K, Ytrebø LM, Fuskevåg OM, Pettersen I, Bertheussen K, Langbakk B, Smedsrød B, Revhaug A. Significant contribution of liver nonparenchymal cells to metabolism of ammonia and lactate and cocultivation augments the functions of a bioartificial liver. Am J Physiol Gastrointest Liver Physiol 2007;293:G75-83. [PMID: 17363468 DOI: 10.1152/ajpgi.00245.2006] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
114 Al-Chalabi A, Matevossian E, V Thaden AK, Luppa P, Neiss A, Schuster T, Yang Z, Schreiber C, Schimmel P, Nairz E, Perren A, Radermacher P, Huber W, Schmid RM, Kreymann B. Evaluation of the Hepa Wash® treatment in pigs with acute liver failure. BMC Gastroenterol 2013;13:83. [PMID: 23668774 DOI: 10.1186/1471-230X-13-83] [Cited by in Crossref: 26] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
115 Carbone M, Lerut J, Neuberger J. How regenerative medicine and tissue engineering may complement the available armamentarium in gastroenterology? World J Gastroenterol 2012;18:6908-17. [PMID: 23322988 DOI: 10.3748/wjg.v18.i47.6908] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
116 Ash SR, Sullivan TA, Carr DJ. Sorbent Suspensions vs. Sorbent Columns for Extracorporeal Detoxification in Hepatic Failure. Therapher Dial 2006;10:145-53. [DOI: 10.1111/j.1744-9987.2006.00356.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 16] [Article Influence: 1.7] [Reference Citation Analysis]
117 Ring A, Gerlach J, Peters G, Pazin BJ, Minervini CF, Turner ME, Thompson RL, Triolo F, Gridelli B, Miki T. Hepatic Maturation of Human Fetal Hepatocytes in Four-Compartment Three-Dimensional Perfusion Culture. Tissue Engineering Part C: Methods 2010;16:835-45. [DOI: 10.1089/ten.tec.2009.0342] [Cited by in Crossref: 29] [Cited by in F6Publishing: 17] [Article Influence: 2.6] [Reference Citation Analysis]
118 Phua J, Lee KH. Liver support devices. Curr Opin Crit Care 2008;14:208-15. [PMID: 18388685 DOI: 10.1097/MCC.0b013e3282f70057] [Cited by in Crossref: 33] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
119 Ash SR, Carr DJ, Sullivan T. Sorbent Suspension Reactor for Extracorporeal Detoxification in Hepatic Failure or Drug Overdose: . ASAIO Journal 2004;50:lviii-lxv. [DOI: 10.1097/01.mat.0000147959.42358.0b] [Cited by in Crossref: 5] [Article Influence: 0.3] [Reference Citation Analysis]
120 Vacanti JP, Kulig KM. Liver cell therapy and tissue engineering for transplantation. Seminars in Pediatric Surgery 2014;23:150-5. [DOI: 10.1053/j.sempedsurg.2014.05.001] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 2.7] [Reference Citation Analysis]
121 Park JK, Lee DH. Bioartificial liver systems: current status and future perspective. J Biosci Bioeng. 2005;99:311-319. [PMID: 16233796 DOI: 10.1263/jbb.99.311] [Cited by in Crossref: 107] [Cited by in F6Publishing: 79] [Article Influence: 6.7] [Reference Citation Analysis]
122 Koch CA, Kanazawa A, Nishitai R, Knudsen BE, Ogata K, Plummer TB, Butters K, Platt JL. Intrinsic Resistance of Hepatocytes to Complement-Mediated Injury. J Immunol 2005;174:7302-9. [DOI: 10.4049/jimmunol.174.11.7302] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 2.1] [Reference Citation Analysis]
123 Chen HS, Joo DJ, Shaheen M, Li Y, Wang Y, Yang J, Nicolas CT, Predmore K, Amiot B, Michalak G, Mounajjed T, Fidler J, Kremers WK, Nyberg SL. Randomized Trial of Spheroid Reservoir Bioartificial Liver in Porcine Model of Posthepatectomy Liver Failure. Hepatology. 2019;69:329-342. [PMID: 30022502 DOI: 10.1002/hep.30184] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 8.0] [Reference Citation Analysis]
124 Auth MK, Woitaschek D, Beste M, Schreiter T, Kim HS, Oppermann E, Joplin RE, Baumann U, Hilgard P, Nadalin S, Markus BH, Blaheta RA. Preservation of the synthetic and metabolic capacity of isolated human hepatocytes by coculture with human biliary epithelial cells. Liver Transpl 2005;11:410-9. [DOI: 10.1002/lt.20367] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 1.6] [Reference Citation Analysis]
125 Stravitz RT. Critical management decisions in patients with acute liver failure. Chest. 2008;134:1092-1102. [PMID: 18988787 DOI: 10.1378/chest.08-1071] [Cited by in Crossref: 68] [Cited by in F6Publishing: 47] [Article Influence: 5.2] [Reference Citation Analysis]
126 Choi WC, Arnaout WC, Villamil FG, Demetriou AA, Vierling JM. Comparison of the applicability of two prognostic scoring systems in patients with fulminant hepatic failure. Korean J Intern Med. 2007;22:93-100. [PMID: 17616024 DOI: 10.3904/kjim.2007.22.2.93] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
127 Zhang Y, Lu J, Li Z, Zhu D, Yu X, Li L. Enhanced cellular functions of hepatocytes in the hyaluronate-alginate-chitosan microcapsules. Int J Artif Organs 2021;44:340-9. [PMID: 32969286 DOI: 10.1177/0391398820959345] [Reference Citation Analysis]
128 Kodali S, Mcguire BM. Diagnosis and Management of Hepatic Encephalopathy in Fulminant Hepatic Failure. Clinics in Liver Disease 2015;19:565-76. [DOI: 10.1016/j.cld.2015.04.006] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
129 Datar S, Wijdicks EF. Neurologic manifestations of acute liver failure. Handb Clin Neurol 2014;120:645-59. [PMID: 24365344 DOI: 10.1016/B978-0-7020-4087-0.00044-9] [Cited by in Crossref: 15] [Cited by in F6Publishing: 2] [Article Influence: 2.1] [Reference Citation Analysis]
130 Diekmann S, Bader A, Schmitmeier S. Present and Future Developments in Hepatic Tissue Engineering for Liver Support Systems : State of the art and future developments of hepatic cell culture techniques for the use in liver support systems. Cytotechnology 2006;50:163-79. [PMID: 19003077 DOI: 10.1007/s10616-006-6336-4] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
131 Glotzbach JP, Wong VW, Gurtner GC, Longaker MT. Regenerative medicine. Curr Probl Surg 2011;48:148-212. [PMID: 21295632 DOI: 10.1067/j.cpsurg.2010.11.002] [Cited by in Crossref: 28] [Cited by in F6Publishing: 20] [Article Influence: 2.8] [Reference Citation Analysis]
132 Ray S, Mehta NN, Golhar A, Nundy S. Post hepatectomy liver failure - A comprehensive review of current concepts and controversies. Ann Med Surg (Lond). 2018;34:4-10. [PMID: 30181871 DOI: 10.1016/j.amsu.2018.08.012] [Cited by in Crossref: 29] [Cited by in F6Publishing: 18] [Article Influence: 9.7] [Reference Citation Analysis]
133 Erro E, Bundy J, Massie I, Chalmers SA, Gautier A, Gerontas S, Hoare M, Sharratt P, Choudhury S, Lubowiecki M. Bioengineering the liver: scale-up and cool chain delivery of the liver cell biomass for clinical targeting in a bioartificial liver support system. Biores Open Access. 2013;2:1-11. [PMID: 23514704 DOI: 10.1089/biores.2012.0286] [Cited by in Crossref: 34] [Cited by in F6Publishing: 29] [Article Influence: 4.3] [Reference Citation Analysis]
134 Miskon A, Yamaoka T, Hyon S, Kodama M, Uyama H. Preservation of Porcine Hepatocytes in Three-Dimensional Bioreactor at Room Temperature Using Epigallocatechin-3-Gallate. Tissue Engineering Part C: Methods 2009;15:345-53. [DOI: 10.1089/ten.tec.2008.0483] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
135 Platt JL, Cascalho M, Piedrahita JA. Xenotransplantation: Progress Along Paths Uncertain from Models to Application. ILAR J. 2018;59:286-308. [PMID: 30541147 DOI: 10.1093/ilar/ily015] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
136 Nedredal GI, Amiot BP, Nyberg P, Luebke-Wheeler J, Lillegard JB, McKenzie TJ, Nyberg SL. Optimization of mass transfer for toxin removal and immunoprotection of hepatocytes in a bioartificial liver. Biotechnol Bioeng 2009;104:995-1003. [PMID: 19557829 DOI: 10.1002/bit.22450] [Cited by in Crossref: 17] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
137 Harimoto N, Taketomi A, Kitagawa D, Kuroda Y, Itoh S, Gion T, Tanaka S, Shirabe K, Shimada M, Maehara Y. The newly established human hepatocyte cell line: application for the bioartificial liver. J Hepatol. 2005;42:557-564. [PMID: 15763342 DOI: 10.1016/j.jhep.2004.11.038] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
138 Wendon J, Cordoba J, Dhawan A, Larsen FS, Manns M, Nevens F, Samuel D, Simpson KJ, Yaron I, Bernardi M. EASL Clinical Practical Guidelines on the management of acute (fulminant) liver failure. Journal of Hepatology 2017;66:1047-81. [DOI: 10.1016/j.jhep.2016.12.003] [Cited by in Crossref: 280] [Cited by in F6Publishing: 201] [Article Influence: 70.0] [Reference Citation Analysis]
139 Wizorek J, Kotru A, Lowell J. Liver Transplantation in Children and Segmental Transplantation. Surgery of the Liver, Biliary Tract and Pancreas. Elsevier; 2007. pp. 1766-77. [DOI: 10.1016/b978-1-4160-3256-4.50127-7] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
140 Ichai P, Saliba F, Antoun F, Azoulay D, Sebagh M, Antonini TM, Escaut L, Delvart V, Castaing D, Samuel D. Acute liver failure due to antitubercular therapy: Strategy for antitubercular treatment before and after liver transplantation. Liver Transpl. 2010;16:1136-1146. [PMID: 20879012 DOI: 10.1002/lt.22125] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 2.1] [Reference Citation Analysis]
141 Tuttle-newhall JE, Collins BH, Desai DM, Kuo PC, Heneghan MA. The current status of living donor liver transplantation. Current Problems in Surgery 2005;42:144-83. [DOI: 10.1067/j.cpsurg.2004.12.003] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
142 Liu T, Zhang S, Chen X, Li G, Wang Y. Hepatic differentiation of mouse embryonic stem cells in three-dimensional polymer scaffolds. Tissue Eng Part A 2010;16:1115-22. [PMID: 19916802 DOI: 10.1089/ten.TEA.2009.0391] [Cited by in Crossref: 36] [Cited by in F6Publishing: 31] [Article Influence: 3.3] [Reference Citation Analysis]
143 Baquerizo A, Bañares R, Saliba F. Current Clinical Status of the Extracorporeal Liver Support Devices. Transplantation of the Liver. Elsevier; 2015. pp. 1463-87. [DOI: 10.1016/b978-1-4557-0268-8.00107-x] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
144 Nardo B, Montalti R, Puviani L, Pacilè V, Beltempo P, Bertelli R, Licursi M, Pariali M, Cianciavicchia D. An Experimental Pilot Study on Controlled Portal Vein Arterialization with an Extracorporeal Device in the Swine Model of Partial Liver Resection and Ischemia. Int J Artif Organs 2006;29:912-8. [DOI: 10.1177/039139880602900912] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
145 Dvir-Ginzberg M, Elkayam T, Cohen S. Induced differentiation and maturation of newborn liver cells into functional hepatic tissue in macroporous alginate scaffolds. FASEB J 2008;22:1440-9. [PMID: 18070820 DOI: 10.1096/fj.07-9277com] [Cited by in Crossref: 48] [Cited by in F6Publishing: 35] [Article Influence: 3.4] [Reference Citation Analysis]
146 Weng J, Han X, Zeng F, Zhang Y, Feng L, Cai L, Liang K, Liu S, Li S, Fu G, Zeng M, Gao Y. Fiber scaffold bioartificial liver therapy relieves acute liver failure and extrahepatic organ injury in pigs. Theranostics 2021;11:7620-39. [PMID: 34335954 DOI: 10.7150/thno.58515] [Reference Citation Analysis]
147 Ishii Y, Saito R, Marushima H, Ito R, Sakamoto T, Yanaga K. Hepatic reconstruction from fetal porcine liver cells using a radial flow bioreactor. World J Gastroenterol 2008;14:2740-7. [PMID: 18461659 DOI: 10.3748/wjg.14.2740] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
148 Kim JE, Chun S, Sinn DH, Kim NJ, Kim S, Kang W, Kim JM, Choi GS, Joh JW, Cho D. Initial experience with high-volume plasma exchange in patients with acute liver failure. J Clin Apher. 2021;36:379-389. [PMID: 33400840 DOI: 10.1002/jca.21873] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
149 Chen Y, Kobayashi N, Suzuki S, Soto-Gutierrez A, Rivas-Carrillo JD, Tanaka K, Navarro-Alvarez N, Fukazawa T, Narushima M, Miki A. Transplantation of human hepatocytes cultured with deleted variant of hepatocyte growth factor prolongs the survival of mice with acute liver failure. Transplantation. 2005;79:1378-1385. [PMID: 15912107 DOI: 10.1097/01.tp.0000160813.37515.97] [Cited by in Crossref: 21] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
150 Nelson ED, Larson E, Joo DJ, Mao S, Glorioso J, Abu Rmilah A, Zhou W, Jia Y, Mounajjed T, Shi M, Bois M, Wood A, Jin F, Whitworth K, Wells K, Spate A, Samuel M, Minshew A, Walters E, Rinaldo P, Lillegard J, Johnson A, Amiot B, Hickey R, Prather R, Platt JL, Nyberg SL. Limited Expansion of Human Hepatocytes in FAH/RAG2-Deficient Swine. Tissue Eng Part A 2021. [PMID: 34309416 DOI: 10.1089/ten.TEA.2021.0057] [Reference Citation Analysis]
151 Gasco J, Rangel-castilla L, Franklin B, Thomas PG, Patterson JT. State-of-the-Art management and Monitoring of Brain Edema and Intracranial Hypertension in Fulminant Hepatic Failure. A Proposed Algorithm. In: Czernicki Z, Baethmann A, Ito U, Katayama Y, Kuroiwa T, Mendelow D, editors. Brain Edema XIV. Vienna: Springer; 2010. pp. 311-4. [DOI: 10.1007/978-3-211-98811-4_58] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
152 Davies NA, Bañares R. A new horizon for liver support in acute liver failure. J Hepatol 2015;63:303-5. [PMID: 26044125 DOI: 10.1016/j.jhep.2015.05.020] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
153 Kandiah PA, Subramanian RM. Extracorporeal Devices. Crit Care Clin 2019;35:135-50. [PMID: 30447776 DOI: 10.1016/j.ccc.2018.08.003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
154 Barshes NR, Gay AN, Williams B, Patel AJ, Awad SS. Support for the Acutely Failing Liver: A Comprehensive Review of Historic and Contemporary Strategies. Journal of the American College of Surgeons 2005;201:458-76. [DOI: 10.1016/j.jamcollsurg.2005.04.007] [Cited by in Crossref: 30] [Cited by in F6Publishing: 17] [Article Influence: 1.9] [Reference Citation Analysis]
155 Michel SG, Madariaga MLL, Villani V, Shanmugarajah K. Current progress in xenotransplantation and organ bioengineering. Int J Surg 2015;13:239-44. [PMID: 25496853 DOI: 10.1016/j.ijsu.2014.12.011] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
156 Li Y, Chen HS, Shaheen M, Joo DJ, Amiot BP, Rinaldo P, Nyberg SL. Cold storage of porcine hepatocyte spheroids for spheroid bioartificial liver. Xenotransplantation 2019;26:e12512. [PMID: 30968460 DOI: 10.1111/xen.12512] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
157 Zhao X, Zhu Y, Laslett AL, Chan HF. Hepatic Differentiation of Stem Cells in 2D and 3D Biomaterial Systems. Bioengineering (Basel) 2020;7:E47. [PMID: 32466173 DOI: 10.3390/bioengineering7020047] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
158 Rovegno M, Vera M, Ruiz A, Benítez C. Current concepts in acute liver failure. Ann Hepatol 2019;18:543-52. [PMID: 31126880 DOI: 10.1016/j.aohep.2019.04.008] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
159 Wencel A, Ciezkowska M, Wisniewska M, Zakrzewska KE, Pijanowska DG, Pluta KD. Effects of genetically modified human skin fibroblasts, stably overexpressing hepatocyte growth factor, on hepatic functions of cocultured C3A cells. Biotechnol Bioeng 2021;118:72-81. [PMID: 32880912 DOI: 10.1002/bit.27551] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
160 Zheng Z, Li X, Li Z, Ma X. Artificial and bioartificial liver support systems for acute and acute-on-chronic hepatic failure: A meta-analysis and meta-regression. Exp Ther Med. 2013;6:929-936. [PMID: 24137292 DOI: 10.3892/etm.2013.1241] [Cited by in Crossref: 39] [Cited by in F6Publishing: 33] [Article Influence: 4.9] [Reference Citation Analysis]
161 Guguen-Guillouzo C, Guillouzo A. General review on in vitro hepatocyte models and their applications. Methods Mol Biol 2010;640:1-40. [PMID: 20645044 DOI: 10.1007/978-1-60761-688-7_1] [Cited by in Crossref: 161] [Cited by in F6Publishing: 133] [Article Influence: 14.6] [Reference Citation Analysis]
162 Faybik P, Krenn CG. Extracorporeal liver support. Curr Opin Crit Care. 2013;19:149-153. [PMID: 23385372 DOI: 10.1097/mcc.0b013e32835eb970] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
163 Khan SA, Shah N, Williams R, Jalan R. Acute liver failure: a review. Clin Liver Dis 2006;10:239-58, vii-viii. [PMID: 16971260 DOI: 10.1016/j.cld.2006.05.010] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 1.3] [Reference Citation Analysis]
164 Durkut S, Elçin AE, Elçin YM. In vitro evaluation of encapsulated primary rat hepatocytes pre- and post-cryopreservation at -80°C and in liquid nitrogen. Artif Cells Nanomed Biotechnol 2015;43:50-61. [PMID: 24059456 DOI: 10.3109/21691401.2013.837476] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
165 Wang X, Magalhães R, Wu Y, Wen F, Gouk SS, Watson PF, Yu H, Kuleshova LL. Development of a modified vitrification strategy suitable for subsequent scale-up for hepatocyte preservation. Cryobiology 2012;65:289-300. [PMID: 22940432 DOI: 10.1016/j.cryobiol.2012.07.080] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
166 Matoori S, Leroux JC. Recent advances in the treatment of hyperammonemia. Adv Drug Deliv Rev 2015;90:55-68. [PMID: 25895618 DOI: 10.1016/j.addr.2015.04.009] [Cited by in Crossref: 58] [Cited by in F6Publishing: 41] [Article Influence: 9.7] [Reference Citation Analysis]
167 Appel J, Vaidya S. Ethical dilemmas in psychiatric evaluations in patients with fulminant liver failure: . Current Opinion in Organ Transplantation 2014;19:175-80. [DOI: 10.1097/mot.0000000000000060] [Cited by in Crossref: 3] [Article Influence: 0.4] [Reference Citation Analysis]
168 Gupta K, Song Z, Tang H, Fong E, Ng I, Yu H. 6.28 Liver Tissue Engineering ☆. Comprehensive Biomaterials II. Elsevier; 2017. pp. 491-512. [DOI: 10.1016/b978-0-12-803581-8.10163-8] [Cited by in Crossref: 2] [Article Influence: 0.5] [Reference Citation Analysis]
169 Aron J, Agarwal B, Davenport A. Extracorporeal support for patients with acute and acute on chronic liver failure. Expert Rev Med Devices 2016;13:367-80. [PMID: 26894968 DOI: 10.1586/17434440.2016.1154455] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
170 Bao J, Fisher JE, Lillegard JB, Wang W, Amiot B, Yu Y, Dietz AB, Nahmias Y, Nyberg SL. Serum-free medium and mesenchymal stromal cells enhance functionality and stabilize integrity of rat hepatocyte spheroids. Cell Transplant. 2013;22:299-308. [PMID: 23006214 DOI: 10.3727/096368912x656054] [Cited by in Crossref: 23] [Cited by in F6Publishing: 11] [Article Influence: 2.6] [Reference Citation Analysis]
171 Hilal-Alnaqbi A, Mourad AH, Yousef BF. Effect of membranes on oxygen transfer rate and consumption within a newly developed three-compartment bioartificial liver device: Advanced experimental and theoretical studies. Biotechnol Appl Biochem. 2014;61:304-315. [PMID: 24164246 DOI: 10.1002/bab.1173] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
172 Bañares R, Catalina MV, Vaquero J. Liver support systems: will they ever reach prime time? Curr Gastroenterol Rep 2013;15:312. [PMID: 23392862 DOI: 10.1007/s11894-013-0312-x] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
173 Li WJ, Zhu XJ, Yuan TJ, Wang ZY, Bian ZQ, Jing HS, Shi X, Chen CY, Fu GB, Huang WJ, Shi YP, Liu Q, Zeng M, Zhang HD, Wu HP, Yu WF, Zhai B, Yan HX. An extracorporeal bioartificial liver embedded with 3D-layered human liver progenitor-like cells relieves acute liver failure in pigs. Sci Transl Med 2020;12:eaba5146. [PMID: 32641490 DOI: 10.1126/scitranslmed.aba5146] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
174 Pei H, Yang Y, Xi J, Bai Z, Yue W, Nan X, Bai C, Wang Y, Pei X. Lineage Restriction and Differentiation of Human Embryonic Stem Cells into Hepatic Progenitors and Zone 1 Hepatocytes. Tissue Engineering Part C: Methods 2009;15:95-104. [DOI: 10.1089/ten.tec.2008.0234] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
175 Hay JE. Acute Liver Failure. Curr Treat Options Gastroenterol 2004;7:459-68. [PMID: 15527712 DOI: 10.1007/s11938-004-0005-5] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
176 Onodera K, Sakata H, Yonekawa M, Kawamura A. Artificial liver support at present and in the future. J Artif Organs. 2006;9:17-28. [PMID: 16614798 DOI: 10.1007/s10047-005-0320-1] [Cited by in Crossref: 28] [Cited by in F6Publishing: 18] [Article Influence: 1.9] [Reference Citation Analysis]
177 Li L, Meng H, Zou Q, Zhang J, Cai L, Yang B, Weng J, Lai L, Yang H, Gao Y. Establishment of gene-edited pigs expressing human blood-coagulation factor VII and albumin for bioartificial liver use. J Gastroenterol Hepatol 2019;34:1851-9. [PMID: 30884543 DOI: 10.1111/jgh.14666] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
178 Shi XL, Gao Y, Yan Y, Ma H, Sun L, Huang P, Ni X, Zhang L, Zhao X, Ren H, Hu D, Zhou Y, Tian F, Ji Y, Cheng X, Pan G, Ding YT, Hui L. Improved survival of porcine acute liver failure by a bioartificial liver device implanted with induced human functional hepatocytes. Cell Res. 2016;26:206-216. [PMID: 26768767 DOI: 10.1038/cr.2016.6] [Cited by in Crossref: 66] [Cited by in F6Publishing: 51] [Article Influence: 13.2] [Reference Citation Analysis]
179 Gonzalez HC, Jafri SM, Gordon SC. Management of Acute Hepatotoxicity Including Medical Agents and Liver Support Systems. Clin Liver Dis 2017;21:163-80. [PMID: 27842770 DOI: 10.1016/j.cld.2016.08.012] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
180 Vaquero J, Blei AT. Cooling the patient with acute liver failure. Gastroenterology 2004;127:1626-9. [DOI: 10.1053/j.gastro.2004.09.058] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
181 O’Grady J. Modern management of acute liver failure. Clin Liver Dis. 2007;11:291-303. [PMID: 17606208 DOI: 10.1016/j.cld.2007.04.011] [Cited by in Crossref: 41] [Cited by in F6Publishing: 23] [Article Influence: 2.9] [Reference Citation Analysis]
182 Fukuda J, Okamura K, Ishihara K, Mizumoto H, Nakazawa K, Ijima H, Kajiwara T, Funatsu K. Differentiation Effects by the Combination of Spheroid Formation and Sodium Butyrate Treatment in Human Hepatoblastoma Cell Line (Hep G2): A Possible Cell Source for Hybrid Artificial Liver. Cell Transplant 2005;14:819-27. [DOI: 10.3727/000000005783982503] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 3.5] [Reference Citation Analysis]
183 Brophy CM, Nyberg SL. Extracorporeal treatment of acute liver failure. Hepatol Res 2008;38 Suppl 1:S34-40. [PMID: 19125950 DOI: 10.1111/j.1872-034X.2008.00424.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
184 Chen Z, Ding YT. Functional evaluation of a new bioartificial liver system in vitro and in vitro. World J Gastroenterol. 2006;12:1312-1316. [PMID: 16534893 DOI: 10.3748/wjg.v12.i8.1857] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
185 Gerlach JC, Zeilinger K, Patzer Ii JF. Bioartificial liver systems: why, what, whither? Regenerative Medicine 2008;3:575-95. [DOI: 10.2217/17460751.3.4.575] [Cited by in Crossref: 40] [Cited by in F6Publishing: 32] [Article Influence: 3.1] [Reference Citation Analysis]
186 Stegmayr B, Ramlow W, Balogun RA. Beyond Dialysis: Current and Emerging Blood Purification Techniques: CURRENT AND EMERGING BLOOD PURIFICATION TECHNIQUES. Seminars in Dialysis 2012;25:207-13. [DOI: 10.1111/j.1525-139x.2011.01034.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 2] [Article Influence: 1.2] [Reference Citation Analysis]
187 Brown RS. MARS preconditioning for living donor liver transplantation: panacea or placebo? Liver Int 2005;25:692-5. [DOI: 10.1111/j.1478-3231.2005.01133.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
188 Debray D, Yousef N, Durand P. New management options for end-stage chronic liver disease and acute liver failure: potential for pediatric patients. Paediatr Drugs 2006;8:1-13. [PMID: 16494508 DOI: 10.2165/00148581-200608010-00001] [Cited by in Crossref: 27] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
189 Akhter J, Johnson L, Gunasegaram A, Riordan S, Morris D. Hepatocyte transplantation: A review of laboratory techniques and clinical experiences. The Surgeon 2007;5:155-64. [DOI: 10.1016/s1479-666x(07)80043-6] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
190 Larsen FS, Schmidt LE, Bernsmeier C, Rasmussen A, Isoniemi H, Patel VC, Triantafyllou E, Bernal W, Auzinger G, Shawcross D, Eefsen M, Bjerring PN, Clemmesen JO, Hockerstedt K, Frederiksen HJ, Hansen BA, Antoniades CG, Wendon J. High-volume plasma exchange in patients with acute liver failure: An open randomised controlled trial. J Hepatol. 2016;64:69-78. [PMID: 26325537 DOI: 10.1016/j.jhep.2015.08.018] [Cited by in Crossref: 268] [Cited by in F6Publishing: 185] [Article Influence: 44.7] [Reference Citation Analysis]
191 Lee SY, Kim HJ, Choi D. Cell sources, liver support systems and liver tissue engineering: alternatives to liver transplantation. Int J Stem Cells. 2015;8:36-47. [PMID: 26019753 DOI: 10.15283/ijsc.2015.8.1.36] [Cited by in Crossref: 47] [Cited by in F6Publishing: 37] [Article Influence: 7.8] [Reference Citation Analysis]
192 Misra AC, Eckhoff D. The development of artificial livers. Curr Opin Organ Transplant 2021. [PMID: 34325441 DOI: 10.1097/MOT.0000000000000907] [Reference Citation Analysis]
193 Soto-Gutierrez A, Navarro-Alvarez N, Rivas-Carrillo JD, Tanaka K, Chen Y, Misawa H, Okitsu T, Noguchi H, Tanaka N, Kobayashi N. Construction and transplantation of an engineered hepatic tissue using a polyaminourethane-coated nonwoven polytetrafluoroethylene fabric. Transplantation 2007;83:129-37. [PMID: 17264808 DOI: 10.1097/01.tp.0000250561.14108.03] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 1.4] [Reference Citation Analysis]
194 Jain V, Dhawan A. Extracorporeal Liver Support Systems in Paediatric Liver Failure. Journal of Pediatric Gastroenterology & Nutrition 2017;64:855-63. [DOI: 10.1097/mpg.0000000000001500] [Cited by in Crossref: 14] [Cited by in F6Publishing: 2] [Article Influence: 3.5] [Reference Citation Analysis]
195 Fiegel HC, Kaufmann PM, Bruns H, Kluth D, Horch RE, Vacanti JP, Kneser U. Hepatic tissue engineering: from transplantation to customized cell-based liver directed therapies from the laboratory. J Cell Mol Med 2008;12:56-66. [PMID: 18021311 DOI: 10.1111/j.1582-4934.2007.00162.x] [Cited by in Crossref: 81] [Cited by in F6Publishing: 73] [Article Influence: 5.8] [Reference Citation Analysis]
196 Chamuleau RAFM, Hoekstra R. End-stage liver failure: filling the treatment gap at the intensive care unit. J Artif Organs 2020;23:113-23. [PMID: 31535298 DOI: 10.1007/s10047-019-01133-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
197 Zhang S, Zhang Y, Chen L, Liu T, Li Y, Wang Y, Geng Y. Efficient large-scale generation of functional hepatocytes from mouse embryonic stem cells grown in a rotating bioreactor with exogenous growth factors and hormones. Stem Cell Res Ther. 2013;4:145. [PMID: 24294908 DOI: 10.1186/scrt356] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
198 Kantola T, Ilmakunnas M, Koivusalo A, Isoniemi H. Bridging Therapies and Liver Transplantation in Acute Liver Failure; 10 Years of MARS Experience from Finland. Scand J Surg 2011;100:8-13. [DOI: 10.1177/145749691110000103] [Cited by in Crossref: 24] [Cited by in F6Publishing: 14] [Article Influence: 2.4] [Reference Citation Analysis]
199 Talbot NC, Caperna TJ, Garrett WM. Growth and Development Symposium: Development, characterization, and use of a porcine epiblast-derived liver stem cell line: ARS-PICM-19. J Anim Sci. 2013;91:66-77. [PMID: 23148238 DOI: 10.2527/jas.2012-5748] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
200 Arkadopoulos N, Kostopanagiotou G, Nastos C, Papalois A, Papoutsidakis N, Kalimeris K, Defterevos G, Kanna T, Polyzois K, Kampouroglou G. Reversal of experimental posthepatectomy liver failure in pigs: a new application of hepatocyte bioreactors. Artif Organs. 2011;35:29-36. [PMID: 20618230 DOI: 10.1111/j.1525-1594.2010.01016.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
201 Farzaneh Z, Pakzad M, Vosough M, Pournasr B, Baharvand H. Differentiation of human embryonic stem cells to hepatocyte-like cells on a new developed xeno-free extracellular matrix. Histochem Cell Biol. 2014;142:217-226. [PMID: 24477550 DOI: 10.1007/s00418-014-1183-4] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.9] [Reference Citation Analysis]
202 Gagliardi G, Laccania G, Boscolo A, La Guardia P, Arrigoni M, Michielan F. Intensive care unit management of fulminant hepatic failure. Transplant Proc. 2006;38:1389-1393. [PMID: 16797312 DOI: 10.1016/j.transproceed.2006.02.056] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
203 Alshamsi F, Alshammari K, Belley-Cote E, Dionne J, Albrahim T, Albudoor B, Ismail M, Al-Judaibi B, Baw B, Subramanian RM, Steadman R, Galusca D, Huang DT, Nanchal R, Al Quraini M, Yuan Y, Alhazzani W; GUIDE Group. Extracorporeal liver support in patients with liver failure: a systematic review and meta-analysis of randomized trials. Intensive Care Med 2020;46:1-16. [PMID: 31588983 DOI: 10.1007/s00134-019-05783-y] [Cited by in Crossref: 21] [Cited by in F6Publishing: 13] [Article Influence: 10.5] [Reference Citation Analysis]
204 Cho CH, Park J, Nagrath D, Tilles AW, Berthiaume F, Toner M, Yarmush ML. Oxygen uptake rates and liver-specific functions of hepatocyte and 3T3 fibroblast co-cultures. Biotechnol Bioeng 2007;97:188-99. [PMID: 17054120 DOI: 10.1002/bit.21225] [Cited by in Crossref: 77] [Cited by in F6Publishing: 62] [Article Influence: 5.5] [Reference Citation Analysis]
205 Stange J. Extracorporeal liver support. Organogenesis 2011;7:64-73. [PMID: 21343699 DOI: 10.4161/org.7.1.14069] [Cited by in Crossref: 23] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
206 Na GH, Kim DG, Kim YH, Han JH, Jung ES. Effects of glucose concentration in the medium on rat hepatocyte culture. Ann Surg Treat Res 2014;87:53-60. [PMID: 25114883 DOI: 10.4174/astr.2014.87.2.53] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
207 Parés A, Mas A. Extracorporeal liver support in severe alcoholic hepatitis. World J Gastroenterol. 2014;20:8011-8017. [PMID: 25009371 DOI: 10.3748/wjg.v20.i25.8011] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
208 Blei A. MARS y el tratamiento de la encefalopatía hepática. Gastroenterología y Hepatología 2005;28:100-4. [DOI: 10.1157/13070709] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
209 Nagata H, Nishitai R, Shirota C, Zhang JL, Koch CA, Cai J, Awwad M, Schuurman HJ, Christians U, Abe M, Baranowska-Kortylewicz J, Platt JL, Fox IJ. Prolonged survival of porcine hepatocytes in cynomolgus monkeys. Gastroenterology 2007;132:321-9. [PMID: 17241882 DOI: 10.1053/j.gastro.2006.10.013] [Cited by in Crossref: 64] [Cited by in F6Publishing: 55] [Article Influence: 4.3] [Reference Citation Analysis]
210 Struecker B, Raschzok N, Sauer IM. Liver support strategies: cutting-edge technologies. Nat Rev Gastroenterol Hepatol. 2014;11:166-176. [PMID: 24166083 DOI: 10.1038/nrgastro.2013.204] [Cited by in Crossref: 110] [Cited by in F6Publishing: 79] [Article Influence: 13.8] [Reference Citation Analysis]
211 Schaefer B, Schmitt CP. The role of molecular adsorbent recirculating system dialysis for extracorporeal liver support in children. Pediatr Nephrol 2013;28:1763-9. [DOI: 10.1007/s00467-012-2348-9] [Cited by in Crossref: 25] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
212 Streetz KL. Bio-artificial liver devices – Tentative, but promising progress. Journal of Hepatology 2008;48:189-91. [DOI: 10.1016/j.jhep.2007.11.008] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
213 Sgroi A, Bühler LH, Morel P, Sykes M, Noel L. International Human Xenotransplantation Inventory. Transplantation 2010;90:597-603. [DOI: 10.1097/tp.0b013e3181eb2e8c] [Cited by in Crossref: 24] [Cited by in F6Publishing: 6] [Article Influence: 2.2] [Reference Citation Analysis]
214 Parsons RF, Baquerizo A, Kirchner VA, Malek S, Desai CS, Schenk A, Finger EB, Brennan TV, Parekh KR, MacConmara M, Brayman K, Fair J, Wertheim JA; ASTS Cellular Transplantation Committee. Challenges, highlights, and opportunities in cellular transplantation: A white paper of the current landscape. Am J Transplant 2021. [PMID: 34212485 DOI: 10.1111/ajt.16740] [Reference Citation Analysis]
215 Liu Q, Liu Z, Dalakas E. Prevalence of porcine endogenous retrovirus in Chinese pig breeds and in patients treated with a porcine liver cell-based bioreactor. World J Gastroenterol 2005;11:4727-30. [PMID: 16094718 DOI: 10.3748/wjg.v11.i30.4727] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
216 Izamis ML, Calhoun C, Uygun BE, Guzzardi MA, Price G, Luitje M, Saeidi N, Yarmush ML, Uygun K. SIMPLE MACHINE PERFUSION SIGNIFICANTLY ENHANCES HEPATOCYTE YIELDS OF ISCHEMIC AND FRESH RAT LIVERS. Cell Med 2013;4:109-23. [PMID: 25431743 DOI: 10.3727/215517912X658927] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
217 Arkadopoulos N, Kalimeris K, Papalois A, Nastos C, Papoutsidakis N, Defterevos G, Zarkadis IK, Mikrou A, Pafiti A, Andreadou I, Kostopanagiotou G, Smyrniotis V. Treatment with Bioartificial Liver Improves Lung Injury in a Swine Model of Partial Hepatectomy and Ischemia/Reperfusion. Int J Artif Organs 2010;33:105-13. [DOI: 10.1177/039139881003300206] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
218 Strom SC, Jorns C. Cell Therapy of Liver Disease. Principles of Regenerative Medicine. Elsevier; 2019. pp. 229-46. [DOI: 10.1016/b978-0-12-809880-6.00016-3] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
219 Wright G, Swain M, Annane D, Saliba F, Samuel D, Arroyo V, DeMorrow S, Witt A. Neuroinflammation in liver disease: sessional talks from ISHEN. Metab Brain Dis 2016;31:1339-54. [PMID: 27726053 DOI: 10.1007/s11011-016-9918-7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
220 Sass DA, Shakil AO. Fulminant hepatic failure. Liver Transpl. 2005;11:594-605. [PMID: 15915484 DOI: 10.1002/lt.20435] [Cited by in Crossref: 114] [Cited by in F6Publishing: 79] [Article Influence: 7.1] [Reference Citation Analysis]
221 Wang X. Intelligent freeform manufacturing of complex organs. Artif Organs 2012;36:951-61. [PMID: 22888830 DOI: 10.1111/j.1525-1594.2012.01499.x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 3.2] [Reference Citation Analysis]
222 Brophy CM, Luebke-Wheeler JL, Amiot BP, Khan H, Remmel RP, Rinaldo P, Nyberg SL. Rat hepatocyte spheroids formed by rocked technique maintain differentiated hepatocyte gene expression and function. Hepatology. 2009;49:578-586. [PMID: 19085959 DOI: 10.1002/hep.22674] [Cited by in Crossref: 110] [Cited by in F6Publishing: 95] [Article Influence: 9.2] [Reference Citation Analysis]
223 Selden C, Bundy J, Erro E, Puschmann E, Miller M, Kahn D, Hodgson H, Fuller B, Gonzalez-Molina J, Le Lay A, Gibbons S, Chalmers S, Modi S, Thomas A, Kilbride P, Isaacs A, Ginsburg R, Ilsley H, Thomson D, Chinnery G, Mankahla N, Loo L, Spearman CW. A clinical-scale BioArtificial Liver, developed for GMP, improved clinical parameters of liver function in porcine liver failure. Sci Rep. 2017;7:14518. [PMID: 29109530 DOI: 10.1038/s41598-017-15021-4] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 5.0] [Reference Citation Analysis]
224 Chamuleau RA, Poyck PP, van de Kerkhove MP. Bioartificial liver: its pros and cons. Ther Apher Dial. 2006;10:168-174. [PMID: 16684219 DOI: 10.1111/j.1744-9987.2006.00359.x] [Cited by in Crossref: 41] [Cited by in F6Publishing: 29] [Article Influence: 2.7] [Reference Citation Analysis]
225 Van Den Broek MAJ, Olde Damink SWM, Dejong CHC, Lang H, Malagó M, Jalan R, Saner FH. Liver failure after partial hepatic resection: definition, pathophysiology, risk factors and treatment: Liver failure after hepatic resection. Liver International 2008;28:767-80. [DOI: 10.1111/j.1478-3231.2008.01777.x] [Cited by in Crossref: 236] [Cited by in F6Publishing: 200] [Article Influence: 18.2] [Reference Citation Analysis]
226 Ekser B, Gridelli B, Tector AJ, Cooper DK. Pig liver xenotransplantation as a bridge to allotransplantation: which patients might benefit? Transplantation. 2009;88:1041-1049. [PMID: 19898198 DOI: 10.1097/tp.0b013e3181ba0555] [Cited by in Crossref: 44] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
227 Izamis ML, Perk S, Calhoun C, Uygun K, Yarmush ML, Berthiaume F. Machine perfusion enhances hepatocyte isolation yields from ischemic livers. Cryobiology 2015;71:244-55. [PMID: 26188080 DOI: 10.1016/j.cryobiol.2015.07.006] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
228 Kramer L, Kodras K. Detoxification as a treatment goal in hepatic failure. Liver Int 2011;31 Suppl 3:1-4. [PMID: 21824274 DOI: 10.1111/j.1478-3231.2011.02587.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
229 Sundaram V, Shaikh OS. Acute liver failure: current practice and recent advances. Gastroenterol Clin North Am 2011;40:523-39. [PMID: 21893272 DOI: 10.1016/j.gtc.2011.06.009] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
230 Yang T, Li C, Zhang L, Li M, Zhou P. A promising hepatocyte-like cell line, CCL-13, exhibits good liver function both in vitro and in an acute liver failure model. Transplant Proc 2013;45:688-94. [PMID: 23498808 DOI: 10.1016/j.transproceed.2012.11.012] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
231 Lu J, Zhang X, Li J, Yu L, Chen E, Zhu D, Zhang Y, Li L. A New Fluidized Bed Bioreactor Based on Diversion-Type Microcapsule Suspension for Bioartificial Liver Systems. PLoS One 2016;11:e0147376. [PMID: 26840840 DOI: 10.1371/journal.pone.0147376] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 3.2] [Reference Citation Analysis]
232 Pless G, Steffen I, Zeilinger K, Sauer IM, Katenz E, Kehr DC, Roth S, Mieder T, Schwartlander R, Muller C, Wegner B, Hout MS, Gerlach JC. Evaluation of Primary Human Liver Cells in Bioreactor Cultures for Extracorporeal Liver Support on the Basis of Urea Production. Artificial Organs 2006;30:686-94. [DOI: 10.1111/j.1525-1594.2006.00285.x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
233 O’Grady J. Bioartificial liver in acute liver failure: impostor or simply misunderstood? Hepatology. 2005;41:383-385. [PMID: 15578652 DOI: 10.1002/hep.20496] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
234 Gu J, Shi X, Ren H, Xu Q, Wang J, Xiao J, Ding Y. Systematic review: extracorporeal bio-artificial liver-support system for liver failure. Hepatol Int 2012;6:670-83. [PMID: 26201519 DOI: 10.1007/s12072-012-9352-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
235 Pless G. Artificial and bioartificial liver support. Organogenesis. 2007;3:20-24. [PMID: 19279696 DOI: 10.4161/org.3.1.3635] [Cited by in Crossref: 25] [Cited by in F6Publishing: 18] [Article Influence: 2.8] [Reference Citation Analysis]
236 Szczepiorkowski ZM, Bandarenko N, Kim HC, Linenberger ML, Marques MB, Sarode R, Schwartz J, Shaz BH, Weinstein R, Wirk A, Winters JL. Guidelines on the use of therapeutic apheresis in clinical practice—Evidence-based approach from the apheresis applications committee of the American society for apheresis. J Clin Apheresis 2007;22:106-75. [DOI: 10.1002/jca.20129] [Cited by in Crossref: 178] [Cited by in F6Publishing: 131] [Article Influence: 12.7] [Reference Citation Analysis]
237 Maguire T, Novik E, Schloss R, Yarmush M. Alginate-PLL microencapsulation: effect on the differentiation of embryonic stem cells into hepatocytes. Biotechnol Bioeng 2006;93:581-91. [PMID: 16345081 DOI: 10.1002/bit.20748] [Cited by in Crossref: 118] [Cited by in F6Publishing: 99] [Article Influence: 7.9] [Reference Citation Analysis]
238 Talbot NC, Caperna TJ, Willard RR, Meekin JH, Garrett WM. Characterization of Two Subpopulations of the PICM-19 Porcine Liver Stem Cell Line for use in Cell-Based Extracorporeal Liver Assistance Devices. Int J Artif Organs 2010;33:348-61. [DOI: 10.1177/039139881003300603] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 3.3] [Reference Citation Analysis]
239 Sentürk E, Esen F, Ozcan PE, Rifai K, Pinarbaşi B, Cakar N, Telci L. The treatment of acute liver failure with fractionated plasma separation and adsorption system: Experience in 85 applications. J Clin Apher 2010;25:195-201. [PMID: 20818714 DOI: 10.1002/jca.20238] [Cited by in Crossref: 32] [Cited by in F6Publishing: 12] [Article Influence: 3.2] [Reference Citation Analysis]
240 Bhatia SN, Underhill GH, Zaret KS, Fox IJ. Cell and tissue engineering for liver disease. Sci Transl Med. 2014;6:245sr2. [PMID: 25031271 DOI: 10.1126/scitranslmed.3005975] [Cited by in Crossref: 178] [Cited by in F6Publishing: 145] [Article Influence: 29.7] [Reference Citation Analysis]
241 van Poll D, Parekkadan B, Cho CH, Berthiaume F, Nahmias Y, Tilles AW, Yarmush ML. Mesenchymal stem cell-derived molecules directly modulate hepatocellular death and regeneration in vitro and in vivo. Hepatology. 2008;47:1634-1643. [PMID: 18395843 DOI: 10.1002/hep.22236] [Cited by in Crossref: 366] [Cited by in F6Publishing: 335] [Article Influence: 28.2] [Reference Citation Analysis]
242 Singhal A, Neuberger J. Acute liver failure: Bridging to transplant or recovery– are we there yet? Journal of Hepatology 2007;46:557-64. [DOI: 10.1016/j.jhep.2007.01.010] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
243 Li LJ, Du WB, Zhang YM, Li J, Pan XP, Chen JJ, Cao HC, Chen Y, Chen YM. Evaluation of a bioartificial liver based on a nonwoven fabric bioreactor with porcine hepatocytes in pigs. J Hepatol. 2006;44:317-324. [PMID: 16356580 DOI: 10.1016/j.jhep.2005.08.006] [Cited by in Crossref: 25] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
244 Rashidi H, Luu NT, Alwahsh SM, Ginai M, Alhaque S, Dong H, Tomaz RA, Vernay B, Vigneswara V, Hallett JM, Chandrashekran A, Dhawan A, Vallier L, Bradley M, Callanan A, Forbes SJ, Newsome PN, Hay DC. 3D human liver tissue from pluripotent stem cells displays stable phenotype in vitro and supports compromised liver function in vivo. Arch Toxicol 2018;92:3117-29. [PMID: 30155720 DOI: 10.1007/s00204-018-2280-2] [Cited by in Crossref: 43] [Cited by in F6Publishing: 32] [Article Influence: 14.3] [Reference Citation Analysis]
245 Lin RZ, Chang HY. Recent advances in three-dimensional multicellular spheroid culture for biomedical research. Biotechnol J. 2008;3:1172-1184. [PMID: 18566957 DOI: 10.1002/biot.200700228] [Cited by in Crossref: 740] [Cited by in F6Publishing: 620] [Article Influence: 61.7] [Reference Citation Analysis]
246 Pitkin Z. New Phase of Growth for Xenogeneic-Based Bioartificial Organs. Int J Mol Sci 2016;17:E1593. [PMID: 27657057 DOI: 10.3390/ijms17091593] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
247 Bellomo R, Ronco C, Mehta RL, Asfar P, Boisramé-Helms J, Darmon M, Diehl JL, Duranteau J, Hoste EAJ, Olivier JB, Legrand M, Lerolle N, Malbrain MLNG, Mårtensson J, Oudemans-van Straaten HM, Parienti JJ, Payen D, Perinel S, Peters E, Pickkers P, Rondeau E, Schetz M, Vinsonneau C, Wendon J, Zhang L, Laterre PF. Acute kidney injury in the ICU: from injury to recovery: reports from the 5th Paris International Conference. Ann Intensive Care 2017;7:49. [PMID: 28474317 DOI: 10.1186/s13613-017-0260-y] [Cited by in Crossref: 60] [Cited by in F6Publishing: 54] [Article Influence: 15.0] [Reference Citation Analysis]
248 Coward SM, Legallais C, David B, Thomas M, Foo Y, Mavri-Damelin D, Hodgson HJ, Selden C. Alginate-encapsulated HepG2 cells in a fluidized bed bioreactor maintain function in human liver failure plasma. Artif Organs. 2009;33:1117-1126. [PMID: 20078562 DOI: 10.1111/j.1525-1594.2009.00821.x] [Cited by in Crossref: 48] [Cited by in F6Publishing: 40] [Article Influence: 4.4] [Reference Citation Analysis]
249 Mas A. Hepatic Encephalopathy: From Pathophysiology to Treatment. Digestion 2006;73:86-93. [DOI: 10.1159/000089783] [Cited by in Crossref: 54] [Cited by in F6Publishing: 32] [Article Influence: 3.6] [Reference Citation Analysis]
250 Yan Q, Deng L, Zhao X, Ye L, Fang Y, Meng Y, Wang Z, Luo X, Liu S, Li A. Establishment and characterization of an immortalized human hepatocyte line for the development of bioartificial liver system. Cytotechnology 2018;70:665-74. [PMID: 29435697 DOI: 10.1007/s10616-017-0167-3] [Reference Citation Analysis]
251 Herrine SK, Moayyedi P, Brown RS, Falck-ytter YT. American Gastroenterological Association Institute Technical Review on Initial Testing and Management of Acute Liver Disease. Gastroenterology 2017;152:648-664.e5. [DOI: 10.1053/j.gastro.2016.12.027] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
252 Glorioso JM, Mao SA, Rodysill B, Mounajjed T, Kremers WK, Elgilani F, Hickey RD, Haugaa H, Rose CF, Amiot B, Nyberg SL. Pivotal preclinical trial of the spheroid reservoir bioartificial liver. J Hepatol. 2015;63:388-398. [PMID: 25817557 DOI: 10.1016/j.jhep.2015.03.021] [Cited by in Crossref: 49] [Cited by in F6Publishing: 40] [Article Influence: 8.2] [Reference Citation Analysis]
253 Blei AT. Brain Edema in Acute Liver Failure. Critical Care Clinics 2008;24:99-114. [DOI: 10.1016/j.ccc.2007.11.001] [Cited by in Crossref: 32] [Cited by in F6Publishing: 27] [Article Influence: 2.5] [Reference Citation Analysis]
254 Miyazawa M, Torii T, Toshimitsu Y, Koyama I. Effect of Mechanical Stress Imposition on Co-culture of Hepatic Parenchymal and Nonparenchymal Cells: Possibility of Stimulating Production of Regenerating Factor. Transplantation Proceedings 2005;37:2398-401. [DOI: 10.1016/j.transproceed.2005.03.103] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
255 Krisper P, Haditsch B, Stauber R, Jung A, Stadlbauer V, Trauner M, Holzer H, Schneditz D. In vivo quantification of liver dialysis: comparison of albumin dialysis and fractionated plasma separation. J Hepatol. 2005;43:451-457. [PMID: 16023249 DOI: 10.1016/j.jhep.2005.02.038] [Cited by in Crossref: 103] [Cited by in F6Publishing: 76] [Article Influence: 6.4] [Reference Citation Analysis]
256 Nicolas C, Wang Y, Luebke-Wheeler J, Nyberg SL. Stem Cell Therapies for Treatment of Liver Disease. Biomedicines 2016;4:E2. [PMID: 28536370 DOI: 10.3390/biomedicines4010002] [Cited by in Crossref: 22] [Cited by in F6Publishing: 14] [Article Influence: 4.4] [Reference Citation Analysis]
257 Inuo H, Eguchi S, Yanaga K, Hamada T, Yamanouchi K, Okudaira S, Kanematsu T. Protective effects of a hibernation-inducer on hepatocyte injury induced by hypothermic preservation. J Hepatobiliary Pancreat Surg. 2007;14:509-513. [PMID: 17909722 DOI: 10.1007/s00534-007-1214-9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
258 Huang Y, Miyamoto D, Hidaka M, Adachi T, Gu WL, Eguchi S. Regenerative medicine for the hepatobiliary system: A review. J Hepatobiliary Pancreat Sci 2020. [PMID: 33314713 DOI: 10.1002/jhbp.882] [Reference Citation Analysis]
259 Nibourg GA, Boer JD, van der Hoeven TV, Ackermans MT, van Gulik TM, Chamuleau RA, Hoekstra R. Perfusion flow rate substantially contributes to the performance of the HepaRG-AMC-bioartificial liver. Biotechnol Bioeng 2012;109:3182-8. [PMID: 22729831 DOI: 10.1002/bit.24586] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
260 Elvevold K, Nedredal GI, Revhaug A, Bertheussen K, Smedsrød B. Long-term preservation of high endocytic activity in primary cultures of pig liver sinusoidal endothelial cells. European Journal of Cell Biology 2005;84:749-64. [DOI: 10.1016/j.ejcb.2005.05.003] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.0] [Reference Citation Analysis]
261 Mas A, Escorsell À, Fernández J. Liver Transplantation for Acute Liver Failure: A Spanish Perspective. Transplantation Proceedings 2010;42:619-21. [DOI: 10.1016/j.transproceed.2010.02.005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
262 Earl TM, Chari RS. (C) I take the whole liver only. Journal of Hepatology 2007;46:578-82. [DOI: 10.1016/j.jhep.2007.01.014] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
263 Sauer M, Altrichter J, Kreutzer HJ, Lögters T, Scholz M, Nöldge-Schomburg G, Schmidt R, Mitzner SR. Extracorporeal cell therapy with granulocytes in a pig model of Gram-positive sepsis. Crit Care Med 2009;37:606-13. [PMID: 19114920 DOI: 10.1097/CCM.0b013e318194aa77] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
264 Nastos C, Kalimeris K, Papoutsidakis N, Defterevos G, Pafiti A, Kalogeropoulou E, Zerva L, Nomikos T, Papalois A, Kostopanagiotou G, Smyrniotis V, Arkadopoulos N. Bioartificial liver attenuates intestinal mucosa injury and gut barrier dysfunction after major hepatectomy: Study in a porcine model. Surgery 2016;159:1501-10. [PMID: 26847802 DOI: 10.1016/j.surg.2015.12.018] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
265 Karvellas CJ, Stravitz RT. High volume plasma exchange in acute liver failure: Dampening the inflammatory cascade? Journal of Hepatology 2016;64:10-2. [DOI: 10.1016/j.jhep.2015.09.010] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
266 van Poll D, Sokmensuer C, Ahmad N, Tilles AW, Berthiaume F, Toner M, Yarmush ML. Elevated hepatocyte-specific functions in fetal rat hepatocytes co-cultured with adult rat hepatocytes. Tissue Eng 2006;12:2965-73. [PMID: 17518664 DOI: 10.1089/ten.2006.12.2965] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 1.6] [Reference Citation Analysis]
267 Yang HR, Thorat A, Jeng LB, Hsu SC, Li PC, Yeh CC, Chen TH, Poon KS. Living Donor Liver Transplantation in Acute Liver Failure Patients with Grade IV Encephalopathy: Is Deep Hepatic Coma Still an Absolute Contraindication? Ann Transplant. 2018;23:176-181. [PMID: 29531210 DOI: 10.12659/aot.907274] [Cited by in Crossref: 6] [Article Influence: 2.0] [Reference Citation Analysis]
268 Gu J, Shi X, Chu X, Zhang Y, Ding Y. Contribution of bone marrow mesenchymal stem cells to porcine hepatocyte culture in vitro. Biochem Cell Biol. 2009;87:595-604. [PMID: 19767823 DOI: 10.1139/o09-017] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
269 Soto-Gutiérrez A, Kobayashi N, Rivas-Carrillo JD, Navarro-Alvarez N, Zhao D, Okitsu T, Noguchi H, Basma H, Tabata Y, Chen Y. Reversal of mouse hepatic failure using an implanted liver-assist device containing ES cell-derived hepatocytes. Nat Biotechnol. 2006;24:1412-1419. [PMID: 17086173 DOI: 10.1038/nbt1257] [Cited by in Crossref: 169] [Cited by in F6Publishing: 147] [Article Influence: 11.3] [Reference Citation Analysis]
270 Lutfi R, Abulebda K, Nitu ME, Molleston JP, Bozic MA, Subbarao G. Intensive Care Management of Pediatric Acute Liver Failure. J Pediatr Gastroenterol Nutr. 2017;64:660-670. [PMID: 27741059 DOI: 10.1097/mpg.0000000000001441] [Cited by in Crossref: 17] [Cited by in F6Publishing: 6] [Article Influence: 5.7] [Reference Citation Analysis]
271 Nussler AK, Zeilinger K, Schyschka L, Ehnert S, Gerlach JC, Yan X, Lee SM, Ilowski M, Thasler WE, Weiss TS. Cell therapeutic options in liver diseases: cell types, medical devices and regulatory issues. J Mater Sci Mater Med 2011;22:1087-99. [PMID: 21461918 DOI: 10.1007/s10856-011-4306-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
272 Millis JM, Losanoff JE. Technology insight: liver support systems. Nat Clin Pract Gastroenterol Hepatol 2005;2:398-405; quiz 434. [PMID: 16265430 DOI: 10.1038/ncpgasthep0254] [Cited by in Crossref: 34] [Cited by in F6Publishing: 29] [Article Influence: 2.1] [Reference Citation Analysis]
273 O'grady J. Personal view: current role of artificial liver support devices. Aliment Pharmacol Ther 2006;23:1549-57. [DOI: 10.1111/j.1365-2036.2006.02931.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
274 Rozga J. Liver support technology--an update. Xenotransplantation. 2006;13:380-389. [PMID: 16925661 DOI: 10.1111/j.1399-3089.2006.00323.x] [Cited by in Crossref: 60] [Cited by in F6Publishing: 38] [Article Influence: 4.3] [Reference Citation Analysis]
275 Lee WM. Recent developments in acute liver failure. Best Pract Res Clin Gastroenterol. 2012;26:3-16. [PMID: 22482521 DOI: 10.1016/j.bpg.2012.01.014] [Cited by in Crossref: 69] [Cited by in F6Publishing: 46] [Article Influence: 8.6] [Reference Citation Analysis]
276 Wang S, Nagrath D. Liver Tissue Engineering. In: Burdick JA, Mauck RL, editors. Biomaterials for Tissue Engineering Applications. Vienna: Springer; 2011. pp. 389-419. [DOI: 10.1007/978-3-7091-0385-2_14] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
277 Park J, Li Y, Berthiaume F, Toner M, Yarmush ML, Tilles AW. Radial flow hepatocyte bioreactor using stacked microfabricated grooved substrates. Biotechnol Bioeng. 2008;99:455-467. [PMID: 17626294 DOI: 10.1002/bit.21572] [Cited by in Crossref: 58] [Cited by in F6Publishing: 44] [Article Influence: 4.5] [Reference Citation Analysis]
278 Wittebole X, Hantson P. Use of the molecular adsorbent recirculating system (MARS™) for the management of acute poisoning with or without liver failure. Clin Toxicol (Phila). 2011;49:782-793. [PMID: 22077243 DOI: 10.3109/15563650.2011.624102] [Cited by in Crossref: 46] [Cited by in F6Publishing: 27] [Article Influence: 5.1] [Reference Citation Analysis]
279 Harris DG, Quinn KJ, Dahi S, Burdorf L, Azimzadeh AM, Pierson RN 3rd. Lung xenotransplantation: recent progress and current status. Xenotransplantation 2014;21:496-506. [PMID: 25040467 DOI: 10.1111/xen.12116] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.9] [Reference Citation Analysis]
280 Kasuya J, Tanishita K. Microporous membrane-based liver tissue engineering for the reconstruction of three-dimensional functional liver tissues in vitro. Biomatter 2012;2:290-5. [PMID: 23507893 DOI: 10.4161/biom.22481] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
281 Vaquero J, Fontana RJ, Larson AM, Bass NM, Davern TJ, Shakil AO, Han S, Harrison ME, Stravitz TR, Muñoz S, Brown R, Lee WM, Blei AT. Complications and use of intracranial pressure monitoring in patients with acute liver failure and severe encephalopathy. Liver Transpl 2005;11:1581-9. [DOI: 10.1002/lt.20625] [Cited by in Crossref: 216] [Cited by in F6Publishing: 135] [Article Influence: 13.5] [Reference Citation Analysis]
282 Koizumi T, Aoki T, Kobayashi Y, Yasuda D, Izumida Y, Jin Z, Nishino N, Shimizu Y, Kato H, Murai N, Niiya T, Enami Y, Mitamura K, Yamamoto T, Kusano M. Long-term maintenance of the drug transport activity in cryopreservation of microencapsulated rat hepatocytes. Cell Transplant 2007;16:67-73. [PMID: 17436856 DOI: 10.3727/000000007783464489] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
283 Hoekstra LT, de Graaf W, Nibourg GA, Heger M, Bennink RJ, Stieger B, van Gulik TM. Physiological and biochemical basis of clinical liver function tests: a review. Ann Surg. 2013;257:27-36. [PMID: 22836216 DOI: 10.1097/sla.0b013e31825d5d47] [Cited by in Crossref: 176] [Cited by in F6Publishing: 75] [Article Influence: 22.0] [Reference Citation Analysis]
284 Zhang S, Liu T, Chen L, Ren M, Zhang B, Wang Z, Wang Y. Bifunctional polyethersulfone hollow fiber with a porous, single-layer skin for use as a bioartificial liver bioreactor. J Mater Sci Mater Med 2012;23:2001-11. [PMID: 22584823 DOI: 10.1007/s10856-012-4673-8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
285 Fernández-Colino A, Iop L, Ventura Ferreira MS, Mela P. Fibrosis in tissue engineering and regenerative medicine: treat or trigger? Adv Drug Deliv Rev 2019;146:17-36. [PMID: 31295523 DOI: 10.1016/j.addr.2019.07.007] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 5.5] [Reference Citation Analysis]
286 Schwartz J, Padmanabhan A, Aqui N, Balogun RA, Connelly-Smith L, Delaney M, Dunbar NM, Witt V, Wu Y, Shaz BH. Guidelines on the Use of Therapeutic Apheresis in Clinical Practice-Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Seventh Special Issue. J Clin Apher. 2016;31:149-162. [PMID: 27322218 DOI: 10.1002/jca.21470] [Cited by in Crossref: 168] [Cited by in F6Publishing: 166] [Article Influence: 42.0] [Reference Citation Analysis]
287 Feng L, He G, Cai L, Fu C, Li Y, Weng J, Huo X, Peng Q, Gao Y. Artificial Liver and Renal Support System for Cynomolgus Monkeys with Surgery-Induced Acute Renal Failure: A Preclinical Study. Biomed Res Int 2018;2018:7456898. [PMID: 29992160 DOI: 10.1155/2018/7456898] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
288 Muraca M. Evolving concepts in cell therapy of liver disease and current clinical perspectives. Dig Liver Dis. 2011;43:180-187. [PMID: 20869923 DOI: 10.1016/j.dld.2010.08.007] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 2.2] [Reference Citation Analysis]
289 Gaspari R, Avolio A, Zileri Dal Verme L, Agnes S, Proietti R, Castagneto M, Gasbarrini A. Molecular Adsorbent Recirculating System in Liver Transplantation: Safety and Efficacy. Transplantation Proceedings 2006;38:3544-51. [DOI: 10.1016/j.transproceed.2006.10.032] [Cited by in Crossref: 22] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
290 Ferenci P, Kramer L. MARS and the failing liver-Any help from the outer space? Hepatology 2007;46:1682-4. [PMID: 18046718 DOI: 10.1002/hep.22031] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
291 Mpabanzi L, Jalan R. Neurological complications of acute liver failure: pathophysiological basis of current management and emerging therapies. Neurochem Int. 2012;60:736-742. [PMID: 22100567 DOI: 10.1016/j.neuint.2011.10.014] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
292 Teng Y, Wang Y, Li S, Wang W, Gu R, Guo X, Nan X, Ma X, Pei X. Treatment of acute hepatic failure in mice by transplantation of mixed microencapsulation of rat hepatocytes and transgenic human fetal liver stromal cells. Tissue Eng Part C Methods 2010;16:1125-34. [PMID: 20121581 DOI: 10.1089/ten.TEC.2009.0374] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
293 Kurtovic J, Riordan SM, Williams R. Fulminant hepatic failure. Curr Treat Options Gastro 2005;8:503-18. [DOI: 10.1007/s11938-005-0037-5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
294 Kleine M, Schrem H, Borlak J, Klempnauer J. Clinical versatility of porcine hepatocytes in the light of interspecies differences in cytochrome P450 regulation and expression. Xenotransplantation 2008;15:208-17. [PMID: 18957043 DOI: 10.1111/j.1399-3089.2008.00478.x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
295 Chun LJ, Tong MJ, Busuttil RW, Hiatt JR. Acetaminophen hepatotoxicity and acute liver failure. J Clin Gastroenterol. 2009;43:342-349. [PMID: 19169150 DOI: 10.1097/mcg.0b013e31818a3854] [Cited by in Crossref: 192] [Cited by in F6Publishing: 66] [Article Influence: 16.0] [Reference Citation Analysis]
296 He YT, Qi YN, Zhang BQ, Li JB, Bao J. Bioartificial liver support systems for acute liver failure: A systematic review and meta-analysis of the clinical and preclinical literature. World J Gastroenterol. 2019;25:3634-3648. [PMID: 31367162 DOI: 10.3748/wjg.v25.i27.3634] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 8] [Article Influence: 14.0] [Reference Citation Analysis]
297 Bernal W, Auzinger G, Dhawan A, Wendon J. Acute liver failure. Lancet. 2010;376:190-201. [PMID: 20638564 DOI: 10.1016/s0140-6736(10)60274-7] [Cited by in Crossref: 614] [Cited by in F6Publishing: 244] [Article Influence: 55.8] [Reference Citation Analysis]
298 Pan X, Li L. Advances in cell sources of hepatocytes for bioartificial liver. Hepatobiliary & Pancreatic Diseases International 2012;11:594-605. [DOI: 10.1016/s1499-3872(12)60230-6] [Cited by in Crossref: 16] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
299 Gaspari R, Cavaliere F, Sollazzi L, Perilli V, Melchionda I, Agnes S, Gasbarrini A, Avolio AW. Molecular adsorbent recirculating system (Mars) in patients with primary nonfunction and other causes of graft dysfunction after liver transplantation in the era of extended criteria donor organs. Transplant Proc. 2009;41:253-258. [PMID: 19249528 DOI: 10.1016/j.transproceed.2008.10.066] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
300 Qin G, Shao JG, Wang B, Shen Y, Zheng J, Liu XJ, Zhang YY, Liu YM, Qin Y, Wang LJ. Artificial liver support system improves short- and long-term outcomes of patients with HBV-associated acute-on-chronic liver failure: a single-center experience. Medicine (Baltimore). 2014;93:e338. [PMID: 25526495 DOI: 10.1097/md.0000000000000338] [Cited by in Crossref: 34] [Cited by in F6Publishing: 16] [Article Influence: 5.7] [Reference Citation Analysis]
301 Pan X, Du W, Yu X, Sheng G, Cao H, Yu C, Lv G, Huang H, Chen Y, Li J, Li L. Establishment and Characterization of Immortalized Porcine Hepatocytes for the Study of Hepatocyte Xenotransplantation. Transplantation Proceedings 2010;42:1899-906. [DOI: 10.1016/j.transproceed.2009.11.043] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
302 Navarro-Alvarez N, Soto-Gutierrez A, Rivas-Carrillo JD, Chen Y, Yamamoto T, Yuasa T, Misawa H, Takei J, Tanaka N, Kobayashi N. Self-assembling peptide nanofiber as a novel culture system for isolated porcine hepatocytes. Cell Transplant 2006;15:921-7. [PMID: 17299997 DOI: 10.3727/000000006783981387] [Cited by in Crossref: 29] [Cited by in F6Publishing: 22] [Article Influence: 2.1] [Reference Citation Analysis]
303 Blau BJ, Miki T. The role of cellular interactions in the induction of hepatocyte polarity and functional maturation in stem cell-derived hepatic cells. Differentiation. 2019;106:42-48. [PMID: 30878880 DOI: 10.1016/j.diff.2019.02.006] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
304 Koutsopoulos S. Molecular fabrications of smart nanobiomaterials and applications in personalized medicine. Adv Drug Deliv Rev. 2012;64:1459-1476. [PMID: 22921596 DOI: 10.1016/j.addr.2012.08.002] [Cited by in Crossref: 47] [Cited by in F6Publishing: 32] [Article Influence: 5.2] [Reference Citation Analysis]
305 Bauer M, Winning J, Kortgen A. Liver failure. Current Opinion in Anaesthesiology 2005;18:111-6. [DOI: 10.1097/01.aco.0000162827.74270.32] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 0.9] [Reference Citation Analysis]
306 Cho CH, Berthiaume F, Tilles AW, Yarmush ML. A new technique for primary hepatocyte expansion in vitro. Biotechnol Bioeng 2008;101:345-56. [PMID: 18465801 DOI: 10.1002/bit.21911] [Cited by in Crossref: 56] [Cited by in F6Publishing: 45] [Article Influence: 4.3] [Reference Citation Analysis]
307 Meyburg J, Schmidt J, Hoffmann GF. Liver cell transplantation in children. Clinical Transplantation 2009;23:75-82. [DOI: 10.1111/j.1399-0012.2009.01113.x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
308 Gu J, Shi X, Zhang Y, Ding Y. Heterotypic interactions in the preservation of morphology and functionality of porcine hepatocytes by bone marrow mesenchymal stem cells in vitro. J Cell Physiol. 2009;219:100-108. [PMID: 19086033 DOI: 10.1002/jcp.21651] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 2.0] [Reference Citation Analysis]
309 Kawazoe Y, Eguchi S, Sugiyama N, Kamohara Y, Fujioka H, Kanematsu T. Comparison between bioartificial and artificial liver for the treatment of acute liver failure in pigs. World J Gastroenterol 2006;12:7503-7. [PMID: 17167841 DOI: 10.3748/wjg.v12.i46.7503] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
310 Bartlett DC, Newsome PN. Hepatocyte cell therapy in liver disease. Expert Rev Gastroenterol Hepatol 2015;9:1261-72. [PMID: 26212798 DOI: 10.1586/17474124.2015.1073106] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
311 Nyberg SL, Hardin J, Amiot B, Argikar UA, Remmel RP, Rinaldo P. Rapid, large-scale formation of porcine hepatocyte spheroids in a novel spheroid reservoir bioartificial liver. Liver Transpl 2005;11:901-10. [DOI: 10.1002/lt.20446] [Cited by in Crossref: 96] [Cited by in F6Publishing: 82] [Article Influence: 6.0] [Reference Citation Analysis]
312 Escorsell À, Castellote J, Sánchez-delgado J, Charco R, Crespo G, Fernández J. Manejo de la insuficiencia hepática aguda grave. Documento de posicionamiento de la Societat Catalana de Digestologia. Gastroenterología y Hepatología 2019;42:51-64. [DOI: 10.1016/j.gastrohep.2018.07.013] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
313 Bolkhir A, Loiselle MM, Evon DM, Hayashi PH. Depression in Primary Caregivers of Patients Listed for Liver or Kidney Transplantation. Prog Transpl 2007;17:193-8. [DOI: 10.1177/152692480701700306] [Cited by in Crossref: 11] [Cited by in F6Publishing: 3] [Article Influence: 2.2] [Reference Citation Analysis]
314 Altrichter J, Sauer M, Kaftan K, Birken T, Gloger D, Gloger M, Henschel J, Hickstein H, Klar E, Koball S, Pertschy A, Nöldge-Schomburg G, Vagts DA, Mitzner SR. Extracorporeal cell therapy of septic shock patients with donor granulocytes: a pilot study. Crit Care 2011;15:R82. [PMID: 21371308 DOI: 10.1186/cc10076] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
315 Nishimura A, Umehara Y, Umehara M, Hakamada K, Narumi S, Toyoki Y, Yoshihara S, Sasaki M. Plasma Exchange-based Plasma Recycling Dialysis System as a Potential Platform for Artificial Liver Support. Artificial Organs 2006;30:629-33. [DOI: 10.1111/j.1525-1594.2006.00273.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
316 O'Grady J. Timing and benefit of liver transplantation in acute liver failure. J Hepatol. 2014;60:663-670. [PMID: 24211740 DOI: 10.1016/j.jhep.2013.10.024] [Cited by in Crossref: 82] [Cited by in F6Publishing: 61] [Article Influence: 10.3] [Reference Citation Analysis]
317 de Vries RJ, Banik PD, Nagpal S, Weng L, Ozer S, van Gulik TM, Toner M, Tessier SN, Uygun K. Bulk Droplet Vitrification: An Approach to Improve Large-Scale Hepatocyte Cryopreservation Outcome. Langmuir 2019;35:7354-63. [PMID: 30514081 DOI: 10.1021/acs.langmuir.8b02831] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 5.5] [Reference Citation Analysis]
318 Munoz SJ. The hepatorenal syndrome. Med Clin North Am. 2008;92:813-37, viii-ix. [PMID: 18570944 DOI: 10.1016/j.mcna.2008.03.007] [Cited by in Crossref: 29] [Cited by in F6Publishing: 21] [Article Influence: 2.2] [Reference Citation Analysis]
319 Zhao LF, Pan XP, Li LJ. Key challenges to the development of extracorporeal bioartificial liver support systems. Hepatobiliary Pancreat Dis Int 2012;11:243-9. [PMID: 22672816 DOI: 10.1016/s1499-3872(12)60155-6] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
320 Sancho-Bru P. [Therapeutic possibilities of stem cells in the treatment of liver diseases]. Gastroenterol Hepatol. 2011;34:701-710. [PMID: 21640436 DOI: 10.1016/j.gastrohep.2011.03.012] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
321 Talbot NC, Blomberg Le Ann, Garrett WM, Caperna TJ. Feeder-independent continuous culture of the PICM-19 pig liver stem cell line. In Vitro Cell Dev Biol Anim. 2010;46:746-757. [PMID: 20607619 DOI: 10.1007/s11626-010-9336-9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
322 Schrem H, Kleine M, Borlak J, Klempnauer J. Physiological incompatibilities of porcine hepatocytes for clinical liver support. Liver Transpl 2006;12:1832-40. [PMID: 17133583 DOI: 10.1002/lt.20918] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
323 O'beirne J, Wendon J. Liver support. Int J Artif Organs 2005;28:477-81. [DOI: 10.1177/039139880502800508] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
324 Li Q, Wang J, Lu M, Qiu Y, Lu H. Acute-on-Chronic Liver Failure From Chronic-Hepatitis-B, Who Is the Behind Scenes. Front Microbiol 2020;11:583423. [PMID: 33365018 DOI: 10.3389/fmicb.2020.583423] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
325 Zhang S, Liu T, Wang Y. Porous and single-skinned polyethersulfone membranes support the growth of HepG2 cells: A potential biomaterial for bioartificial liver systems. J Biomater Appl 2012;27:359-66. [DOI: 10.1177/0885328211406299] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
326 Cernigliaro V, Peluso R, Zedda B, Silengo L, Tolosano E, Pellicano R, Altruda F, Fagoonee S. Evolving Cell-Based and Cell-Free Clinical Strategies for Treating Severe Human Liver Diseases. Cells 2020;9:E386. [PMID: 32046114 DOI: 10.3390/cells9020386] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 8.0] [Reference Citation Analysis]
327 Heydari Z, Najimi M, Mirzaei H, Shpichka A, Ruoss M, Farzaneh Z, Montazeri L, Piryaei A, Timashev P, Gramignoli R, Nussler A, Baharvand H, Vosough M. Tissue Engineering in Liver Regenerative Medicine: Insights into Novel Translational Technologies. Cells 2020;9:E304. [PMID: 32012725 DOI: 10.3390/cells9020304] [Cited by in Crossref: 16] [Cited by in F6Publishing: 9] [Article Influence: 16.0] [Reference Citation Analysis]
328 Pless G. Bioartificial liver support systems. Methods Mol Biol. 2010;640:511-523. [PMID: 20645071 DOI: 10.1007/978-1-60761-688-7_28] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 1.8] [Reference Citation Analysis]
329 Bernal W, Lee WM, Wendon J, Larsen FS, Williams R. Acute liver failure: A curable disease by 2024? J Hepatol. 2015;62:S112-S120. [PMID: 25920080 DOI: 10.1016/j.jhep.2014.12.016] [Cited by in Crossref: 130] [Cited by in F6Publishing: 100] [Article Influence: 26.0] [Reference Citation Analysis]
330 Munoz SJ. Hepatic encephalopathy. Med Clin North Am. 2008;92:795-812, viii. [PMID: 18570943 DOI: 10.1016/j.mcna.2008.03.009] [Cited by in Crossref: 51] [Cited by in F6Publishing: 36] [Article Influence: 3.9] [Reference Citation Analysis]
331 De Wolf AM. Preoperative optimization of patients with liver disease. Current Opinion in Anaesthesiology 2005;18:325-31. [DOI: 10.1097/01.aco.0000169242.03754.cc] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
332 Cheungpasitporn W, Thongprayoon C, Zoghby ZM, Kashani K. MARS: Should I Use It? Adv Chronic Kidney Dis 2021;28:47-58. [PMID: 34389137 DOI: 10.1053/j.ackd.2021.02.004] [Reference Citation Analysis]
333 Andria B, Bracco A, Cirino G, Chamuleau RA. Liver Cell Culture Devices. Cell Med 2010;1:55-70. [PMID: 26998397 DOI: 10.3727/215517910X519274] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
334 Sussman NL, Kelly JH. Artificial liver. Clin Gastroenterol Hepatol 2014;12:1439-42. [PMID: 24909908 DOI: 10.1016/j.cgh.2014.06.002] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
335 Yu Y, Fisher JE, Lillegard JB, Rodysill B, Amiot B, Nyberg SL. Cell therapies for liver diseases. Liver Transpl. 2012;18:9-21. [PMID: 22140063 DOI: 10.1002/lt.22467] [Cited by in Crossref: 69] [Cited by in F6Publishing: 60] [Article Influence: 7.7] [Reference Citation Analysis]
336 Szczepiorkowski ZM, Winters JL, Bandarenko N, Kim HC, Linenberger ML, Marques MB, Sarode R, Schwartz J, Weinstein R, Shaz BH; Apheresis Applications Committee of the American Society for Apheresis. Guidelines on the use of therapeutic apheresis in clinical practice--evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis. J Clin Apher. 2010;25:83-177. [PMID: 20568098 DOI: 10.1002/jca.20240] [Cited by in Crossref: 366] [Cited by in F6Publishing: 274] [Article Influence: 33.3] [Reference Citation Analysis]
337 Rodriguez JV, Pizarro MD, Scandizzi AL, Guibert EE, Almada LL, Mamprin ME. Construction and Performance of a Minibioreactor Suitable as Experimental Bioartificial Liver. Artificial Organs 2008;32:323-8. [DOI: 10.1111/j.1525-1594.2007.00435.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
338 Patel P, Okoronkwo N, Pyrsopoulos NT. Future Approaches and Therapeutic Modalities for Acute Liver Failure. Clin Liver Dis 2018;22:419-27. [PMID: 29605076 DOI: 10.1016/j.cld.2018.01.011] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]